CCC Intelligent Solutions’ proposed $7.75-a-share merger
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
CCC Intelligent Solutions Holdings Inc. has agreed to a proposed merger under which each eligible common share would convert, if the deal closes, into $7.75 per share in cash, without interest. Treasury shares, shares owned by Parent or its subsidiaries, shares with properly exercised appraisal rights and Company restricted stock awards are excluded. The price is approximately 44% above CCC’s unaffected $5.38 closing price on July 9, 2026, and approximately 59% above its 30-day average price as of that date. At closing, CCC would remain as Parent’s wholly owned subsidiary.
The board recommends votes “FOR” the merger, advisory compensation and adjournment proposals. Merger approval requires the affirmative vote of holders of a majority of outstanding shares entitled to vote; the advisory compensation vote is non-binding. Closing also requires expiration or termination of the HSR Act waiting period. Parent and Merger Sub obtained commitments of up to $3.4785 billion in equity and up to $2.075 billion in senior secured first-lien facilities, plus a bridge facility of up to $1.1 billion. The merger is not subject to a financing condition.
Filing Explained
Specified qualifying job separations can accelerate vesting and payment of restricted cash awards.
The
For unvested RSAs and RSUs, payment of the restricted cash award remains subject to the corresponding award’s terms; for unvested PSUs, the award amount is based on the greater of actual performance through the effective time or target-level performance. Options with an exercise price below
The proxy says appraisal eligibility requires continuous ownership through the effective time, not voting in favor, a written demand before the merger vote and compliance with Delaware procedures; court-determined fair value may be higher than, equal to or lower than the merger consideration.
Key Figures
Key Terms
Per Share Price financial
HSR Act waiting period regulatory
appraisal rights regulatory
Restricted Cash Awards financial
Requisite Stockholder Approval technical
Superior Proposal technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is CCC’s proposed merger price per share?
What premium does CCC’s proposed merger price represent?
What vote is required to approve CCC’s merger?
What happens to CCC stock options if the merger closes?
How can CCC shareholders seek appraisal instead of merger consideration?
AI-generated analysis. How Rhea-AI works. Not financial advice.
TABLE OF CONTENTS
Filed by the Registrant | ☒ | ||
Filed by a Party other than the Registrant | ☐ | ||
☒ | Preliminary Proxy Statement |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☐ | Definitive Proxy Statement |
☐ | Definitive Additional Materials |
☐ | Soliciting Material under §240.14a-12 |
CCC INTELLIGENT SOLUTIONS HOLDINGS INC. |
(Name of Registrant as Specified In Its Charter) |
(Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
☐ | No fee required. |
☐ | Fee paid previously with preliminary materials. |
☒ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
TABLE OF CONTENTS

TABLE OF CONTENTS
TABLE OF CONTENTS

1. | To consider and vote on a proposal to adopt the Agreement and Plan of Merger, dated as of October 14, 2026, as amended on November 20, 2026 (and as it may be further amended, supplemented or otherwise modified from time to time, the “Merger Agreement”), by and among the Company, Mozart Parent, LLC, a Delaware limited liability company (“Parent”), and Mozart Merger Sub (DE), Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”). Pursuant to the terms of the Merger Agreement, Merger Sub will be merged with and into the Company, with the Company continuing as the surviving corporation and as a wholly owned subsidiary of Parent (the “Merger”) (the “Merger Proposal”); |
2. | To consider and vote on a proposal to approve, on an advisory, non-binding basis, the specified compensation that will or may be paid or may become payable to the Company’s named executive officers in connection with the Merger (the “Advisory Compensation Proposal”); and |
3. | To consider and vote on a proposal to approve the adjournment of the Special Meeting to a later date or dates, from time to time, if necessary, in accordance with the terms of the Merger Agreement, to solicit additional proxies in the event there are not sufficient votes at the time of the Special Meeting to approve the Merger Proposal (the “Adjournment Proposal”). |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
Page | |||
SUMMARY | 1 | ||
The Parties (page 24) | 1 | ||
The Merger (page 33) | 2 | ||
The Special Meeting (page 25) | 3 | ||
Reasons for the Merger; Recommendation of the Transaction Committee and the Company Board (page 47) | 4 | ||
Opinion of the Company Financial Advisor (page 56, Annex B) | 4 | ||
Certain Effects of the Merger (page 68) | 5 | ||
Effects on the Company if the Merger Is Not Completed (page 69) | 5 | ||
Treatment of Company Equity Awards in the Merger (page 85) | 5 | ||
Interests of the Company’s Directors and Executive Officers in the Merger (page 71) | 7 | ||
Voting by the Company's Directors and Executive Officers (page 29) | 7 | ||
Financing of the Merger (page 70) | 7 | ||
Conditions to Consummation of the Merger (page 104) | 8 | ||
Regulatory Approvals Required for the Merger (page 80) | 8 | ||
No Solicitation of Other Offers (page 97) | 9 | ||
Termination of the Merger Agreement (page 106) | 9 | ||
Termination Fees (page 107) | 10 | ||
Legal Proceedings Regarding the Merger (page 80) | 10 | ||
Delisting and Deregistration of Company Common Stock (page 81) | 11 | ||
Appraisal Rights (page 116) | 11 | ||
Material U.S. Federal Income Tax Considerations (page 77) | 12 | ||
Additional Information (page 125) | 12 | ||
QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING AND THE MERGER | 13 | ||
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS | 22 | ||
THE PARTIES | 24 | ||
THE SPECIAL MEETING | 25 | ||
Date, Time and Place | 25 | ||
Purpose of the Special Meeting | 25 | ||
Recommendation of the Transaction Committee and the Company Board | 25 | ||
Record Date and Company Stockholders Entitled to Vote | 25 | ||
Quorum | 26 | ||
Vote Required | 26 | ||
Tabulation of Votes; Results | 26 | ||
Voting Procedures | 26 | ||
Revocation of Proxies | 28 | ||
Voting at the Special Meeting | 28 | ||
Solicitation of Proxies | 28 | ||
Adjournments | 29 | ||
Voting by the Company’s Directors and Executive Officers | 29 | ||
Assistance | 29 | ||
PROPOSAL 1: ADOPTION OF THE MERGER AGREEMENT | 30 | ||
PROPOSAL 2: APPROVAL OF THE ADVISORY COMPENSATION PROPOSAL | 31 | ||
PROPOSAL 3: ADJOURNMENT PROPOSAL | 32 | ||
THE MERGER | 33 | ||
General Description of the Merger | 33 | ||
Background of the Merger | 33 | ||
Reasons for the Merger; Recommendation of the Transaction Committee and the Company Board | 47 | ||
Opinion of the Company Financial Advisor | 56 | ||
TABLE OF CONTENTS
Page | |||
Certain Company Management Projections | 64 | ||
Certain Effects of the Merger | 68 | ||
Effects on the Company if the Merger Is Not Completed | 69 | ||
Financing of the Merger | 70 | ||
Interests of the Company’s Directors and Executive Officers in the Merger | 71 | ||
Material U.S. Federal Income Tax Considerations | 77 | ||
Regulatory Approvals Required for the Merger | 80 | ||
Legal Proceedings Regarding the Merger | 80 | ||
Delisting and Deregistration of Company Common Stock | 81 | ||
THE MERGER AGREEMENT | 82 | ||
Explanatory Note Regarding the Merger Agreement | 82 | ||
Structure of the Merger | 82 | ||
Consummation and Effectiveness of the Merger | 82 | ||
Consideration to Be Received in the Merger | 83 | ||
Procedures for Receiving Per Share Price | 83 | ||
Treatment of Company Equity Awards in the Merger | 85 | ||
Effect on Other Company Securities; Company Earnout Shares | 87 | ||
Dissenting Company Shares | 87 | ||
Effects of the Merger; Certificate of Incorporation; Bylaws; Directors and Officers | 88 | ||
Representations and Warranties | 88 | ||
Conduct of Business by the Company Prior to Consummation of the Merger | 92 | ||
Regulatory Filings; Efforts | 95 | ||
No Solicitation of Other Offers | 97 | ||
Financing Cooperation | 99 | ||
Indemnification of Directors and Officers and Insurance | 101 | ||
Employee Matters | 102 | ||
Other Covenants and Agreements | 104 | ||
Conditions to Consummation of the Merger | 104 | ||
Termination of the Merger Agreement | 106 | ||
Termination Fees | 107 | ||
Superior Proposal and Change of Recommendation | 108 | ||
Amendment and Waiver | 110 | ||
Governing Law; Jurisdiction and Waiver of Jury Trial | 110 | ||
Specific Performance | 111 | ||
MARKET INFORMATION AND DIVIDENDS | 113 | ||
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT | 114 | ||
APPRAISAL RIGHTS | 116 | ||
General | 116 | ||
How to Exercise and Perfect Your Appraisal Rights | 117 | ||
Who May Exercise Appraisal Rights | 118 | ||
Surviving Corporation’s Actions After Completion of the Merger | 119 | ||
HOUSEHOLDING | 123 | ||
FUTURE STOCKHOLDER PROPOSALS | 124 | ||
WHERE YOU CAN FIND ADDITIONAL INFORMATION | 125 | ||
Annex A-1 — Merger Agreement | A-1 | ||
Annex A-2 — First Amendment to Merger Agreement | A-80 | ||
Annex B — Opinion of the Company Financial Advisor | B-1 | ||
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | the Company’s executive officers and directors hold equity-based awards that will be afforded the treatment described immediately above and under the section of this proxy statement titled “The Merger Agreement — Treatment of Company Equity Awards in the Merger”; |
• | the Company’s executive officers are party to existing employment agreements with the Company that provide for certain severance benefits if their employment terminates in certain circumstances; and |
• | the Company’s directors and executive officers are entitled to continued indemnification and insurance coverage following the Merger under the Merger Agreement. See the section of this proxy statement titled “The Merger Agreement — Indemnification of Directors and Officers and Insurance.” |
TABLE OF CONTENTS
• | the adoption of the Merger Agreement by the Company stockholders; |
• | no law, injunction or order by any governmental authority of competent jurisdiction prohibiting, enjoining or otherwise making illegal the consummation of the Merger will have been enacted, entered or promulgated and be continuing in effect; and |
• | the waiting periods (including any extension thereof, including any agreement with a governmental authority to delay the Closing) applicable to the Merger under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”) will have expired or otherwise been terminated. |
• | subject to certain materiality and other qualifiers, the accuracy of the representations and warranties of the other party; |
• | the other party has complied in all material respects with the covenants and obligations of the Merger Agreement required to be performed and complied with by such party at or prior to the Closing; |
• | the delivery of a customary closing certificate signed on behalf of the respective party by an officer of such party certifying certain conditions have been satisfied; |
• | in the case of Parent’s and Merger Sub’s obligations, the absence of a Company Material Adverse Effect (as defined in the Merger Agreement and which term is described in the section of this proxy statement titled “The Merger Agreement — Representations and Warranties”); and |
• | in the case of Parent’s and Merger Sub’s obligations, the delivery of a certificate from the Company to Parent, in a form reasonably satisfactory to Parent, certifying that the Company is not, and has not been during the applicable period described in the U.S. Internal Revenue Code of 1986 (the “Code”), a “United States real property holding corporation” (as defined in the Code), together with a copy of the notice to the U.S. Internal Revenue Service (the “IRS”). |
TABLE OF CONTENTS
• | if the Merger is not consummated on or before 11:59 p.m. (New York City time) on April 14, 2027 (the “Termination Date”); |
• | if the Requisite Stockholder Approval is not obtained at the Special Meeting at which a vote is taken on the Merger; |
TABLE OF CONTENTS
• | if the other party (or, in the case of the Company’s termination right, Parent or Merger Sub) breaches or fails to perform any of its representations, warranties, covenants or other agreements contained in the Merger Agreement in a manner that would cause the conditions to Closing to not be satisfied and, if capable of being cured, such party fails to cure such breach within the applicable cure period; |
• | if there is a final and non-appealable permanent injunction or other judgment or order issued by any court or other governmental authority of competent jurisdiction preventing the consummation of the Merger, or any statute, rule or regulation that has been enacted, entered or enforced, which, in each case, prohibits, makes illegal or enjoins the consummation of the Merger; and |
• | by mutual written agreement of Parent and the Company at any time prior to the Effective Time (whether prior to or after the receipt of the Requisite Stockholder Approval). |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | a proposal to adopt the Merger Agreement (the “Merger Proposal”); |
• | a proposal to approve, on an advisory, non-binding basis, the specified compensation that will or may be paid or may become payable to the Company’s named executive officers in connection with the Merger (the “Advisory Compensation Proposal”); and |
TABLE OF CONTENTS
• | a proposal to adjourn the Special Meeting to a later date or dates, from time to time, if necessary, in accordance with the terms of the Merger Agreement, to solicit additional proxies in the event there are not sufficient votes at the time of the Special Meeting to approve the Merger Proposal (the “Adjournment Proposal”). |
Voting Matter | Voting Options | Vote Required | Broker Discretionary Voting Allowed | Effect of Broker Non-Votes | Effect of Abstentions | ||||||||||
Proposal 1: The Merger Proposal | For, against, or abstain | Affirmative vote of the Company stockholders holding a majority of the outstanding shares of Company Common Stock entitled to vote | No | N/A(1)(2) | Against | ||||||||||
Proposal 2: The Advisory Compensation Proposal | For, against, or abstain | With a quorum present, majority of the votes properly cast for and against the proposal | No | N/A(1)(3) | No effect | ||||||||||
Proposal 3: The Adjournment Proposal(4) | For, against, or abstain | With a quorum present: Majority of the votes properly cast for and against the proposal | No | N/A(1)(3) | With a quorum: No effect | ||||||||||
Without a quorum: Holders of a majority of the voting power present at the Special Meeting | Without a quorum: Against | ||||||||||||||
(1) | Each proposal to be considered at the Special Meeting is expected to be deemed a “non-routine” matter. As a result, if you do not provide any voting instructions to your broker, bank, or other nominee, your shares will not be deemed present for any purpose at the Special Meeting, including for purposes of determining whether a quorum exists. Accordingly, no broker non-votes are expected in connection with the Special Meeting. |
(2) | Although no broker non-votes are expected, a failure to provide any instructions to the broker, bank, or other nominee holding your shares of Company Common Stock will, without resulting in a broker non-vote, have the same effect as a vote “Against” the Merger Proposal. |
(3) | Although no broker non-votes are expected, a failure to provide any instructions to the broker, bank, or other nominee holding your shares of Company Common Stock will, without resulting in a broker non-vote and assuming a quorum is present, have no effect on the outcome of the Advisory Compensation Proposal or the Adjournment Proposal. |
TABLE OF CONTENTS
(4) | Subject to the terms of the Merger Agreement, the Company retains authority, to the extent set forth in its Bylaws and Delaware law, to adjourn the Special Meeting for any other purpose, or to postpone the Special Meeting before it is convened, without the vote or consent of any of the Company stockholders. Please be advised that the Company does not intend to call a vote on the Adjournment Proposal if the Merger Proposal is approved at the Special Meeting. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement, including circumstances requiring us to pay the Company Termination Fee pursuant to the Merger Agreement; |
• | failure to satisfy the conditions precedent to consummate the Merger, including the failure to receive the Requisite Stockholder Approval or obtain required regulatory approvals; |
• | the risk that required regulatory approvals may not be obtained in a timely manner or at all, or may be obtained subject to conditions that are not anticipated; |
• | the risk that restrictions on the operation of our business during the pendency of the Merger may impact our ability to pursue certain business opportunities or strategic transactions or undertake certain actions we might otherwise have taken; |
• | potential litigation relating to, or other unexpected costs resulting from, the Merger; |
• | the effect of the announcement or pendency of the Merger on our business relationships, operating results and business generally, including the risk of disruption of management’s attention from our ongoing business operations; |
• | the possibility that a competing Acquisition Proposal which constitutes, or could reasonably be expected to lead to, a Superior Proposal will be made, and the risk that announcements relating to the Merger could have adverse effects on the market price of Company Common Stock; |
• | our revenues, the concentration of our customers and the ability to retain our current customers; |
• | our ability to negotiate with our customers on favorable terms; |
• | our ability to maintain and grow our brand and reputation cost-effectively; |
• | the execution of our growth strategy; |
• | the impact of factors outside of our control including public health outbreaks, natural catastrophes, war and terrorism; |
• | our projected financial information, growth rate and market opportunity; |
• | the health of our industry, claim volumes, and market conditions; |
• | changes in the insurance and automotive collision industries, including the adoption of new technologies; |
• | global economic conditions and geopolitical events; |
• | competition in our market and our ability to retain and grow market share; |
• | our ability to develop, introduce and market new enhanced versions of our solutions; |
TABLE OF CONTENTS
• | our sales and implementation cycles; |
• | the ability of our research and development efforts to create significant new revenue streams; |
• | changes in applicable laws or regulations; |
• | changes in international economic, political, social and governmental conditions and policies, including corruption risks in China and other countries; |
• | our reliance on third-party data, technology and intellectual property; |
• | our ability to protect our intellectual property; |
• | our ability to keep our data and information systems secure from data security breaches; |
• | changes in our customers’ or the public’s perceptions regarding the use of AI; |
• | our ability to acquire or invest in companies or pursue business partnerships; |
• | our ability to raise financing in the future and improve our capital structure; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors; |
• | our estimates regarding expenses, future revenue, capital requirements and needs for additional financing; |
• | our ability to expand or maintain our existing customer base; |
• | our ability to service our indebtedness; and |
• | other factors set forth in our SEC filings. |
TABLE OF CONTENTS
TABLE OF CONTENTS
• | a proposal to adopt the Merger Agreement (the “Merger Proposal”); |
• | a proposal to approve, on an advisory, non-binding basis, the specified compensation that will or may be paid or may become payable to the Company’s named executive officers in connection with the Merger (the “Advisory Compensation Proposal”); and |
• | a proposal to adjourn the Special Meeting to a later date or dates, from time to time, if necessary, in accordance with the terms of the Merger Agreement, to solicit additional proxies in the event there are not sufficient votes at the time of the Special Meeting to approve the Merger Proposal (the “Adjournment Proposal”). |
TABLE OF CONTENTS
TABLE OF CONTENTS
• | By Internet. If you have Internet access, you may submit your proxy by going to www.proxyvote.com and following the instructions on how to complete an electronic proxy card. You will need the control number included on your proxy card in order to authorize a proxy to vote by Internet. Internet voting is available until 11:59 p.m., Eastern Time, on [•], 2026. |
• | By Telephone. If you have access to a touch-tone telephone, you may submit your proxy by calling +1 (800) 690-6903 and following the recorded instructions. You will need the control number included on your proxy card in order to authorize a proxy to vote by telephone. Telephone voting is available until 11:59 p.m., Eastern Time, on [•], 2026. |
• | By Mail. You may authorize a proxy to vote by mail by completing, signing and dating the accompanying proxy card and returning it in the prepaid reply envelope provided so that it is received prior to the Special Meeting. You should sign your name exactly as it appears on the proxy card. If you are signing in a representative capacity (for example, as guardian, executor, trustee, custodian, attorney or officer of a corporation), please indicate your name and title or capacity. |
TABLE OF CONTENTS
• | Stockholders of record: If you are a holder of record, in order to participate in the Special Meeting, you will need your 16-digit control number included on the proxy card previously distributed to you. If you are a holder of record, you may vote electronically during the Special Meeting by following the instructions available on www.virtualshareholdermeeting.com/[•]. |
• | Stockholders holding shares in “street” name: If your shares are beneficially held in “street name” through a brokerage firm, bank, trust or other similar organization and you do not have a 16-digit control number, in order to participate in the Special Meeting, you must first obtain a legal proxy from your broker, bank or other nominee reflecting the number of shares of Company Common Stock you held as of the Record Date, your name and email address. If you beneficially hold your shares of Company Common Stock in “street name,” you must obtain the appropriate documents from your broker, bank, trustee, or nominee, giving you the right to vote the shares at the Special Meeting. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | the fact that the Per Share Price of $7.75 is all cash, which provides certainty, immediate value and liquidity to Company stockholders (other than the Rollover Investors, with respect to the shares of Company Common Stock to be contributed to Topco pursuant to the Rollover Agreements) upon consummation of the Merger, while eliminating exposure to business and execution risk, compared to continuing to operate the Company as a standalone company; |
TABLE OF CONTENTS
• | the historical market prices, volatility and trading information with respect to Company Common Stock, including the fact that $7.75 per share to be received by Company stockholders represents a premium of approximately (a) 44% over the unaffected closing price of Company Common Stock of $5.38 on July 9, 2026, the last full trading day prior to the publication of market rumors regarding a potential acquisition of the Company, (b) 59% over the unaffected 30-trading day volume-weighted average price of Company Common Stock of $4.87 as of the last full trading day prior to the publication of market rumors regarding a potential acquisition of the Company and (c) 48% over the unaffected 90-trading day average price of Company Common Stock of $5.24 as of the last full trading day prior to the publication of market rumors regarding a potential acquisition of the Company; |
• | the belief that the Per Share Price of $7.75 is more favorable to Company stockholders on a risk-adjusted basis than the potential value that might result from other alternatives reasonably available to the Company, including continuing as an independent public company, based upon the Transaction Committee members’ knowledge of the Company’s business, assets, financial condition and results of operations as well as the industry in which the Company operates, the execution challenges that the Company potentially faces and general market dynamics, and taking into account: |
• | the Company’s historical and projected financial performance, including the Projections described in the section of this proxy statement titled “The Merger — Certain Company Management Projections,” and the fact that the full realization of the Projections was subject to significant execution risk; |
• | the challenges and risks that the Company has faced, and would likely continue to face, if it remained an independent public company, including, among other things, the need for further proof points for the Company’s AI-led growth, the need to adopt and integrate evolving technologies, including AI, the possibility that advanced driver-assistance systems and other vehicle technology could reduce accident frequency, the Company’s concentration among insurance carrier customers, the competitive landscape, financial and execution risks associated with the Company’s standalone plan, and the potential impact of those factors on the trading price of Company Common Stock (which cannot be quantified numerically); |
• | the impact and status of general industry, economic and market conditions and trends relevant to the Company’s business, including information regarding recent AI-related developments affecting software companies more broadly and the potential impact that advancements in AI could have on the Company’s industry and long-term business prospects, and, in light of such conditions and trends, the risks and challenges to value creation associated with continuing to operate the Company as a standalone public company; and |
• | the risk that, absent the Merger, the trading price of Company Common Stock would not achieve a value comparable to the Per Share Price within a reasonable timeframe, including due to the potential negative impact of stock market disruptions relating to advancements in AI on the relative trading performance of software businesses or, more generally, recent market volatility; |
• | the sale process conducted by the Company, with the assistance of Morgan Stanley and Kirkland, including that the Company (i) discussed possible interest in a potential transaction with 39 potential counterparties (consisting of 31 financial sponsors and 8 strategic parties), of which 22 were contacted by Morgan Stanley at the direction of the Company and 17 contacted the Company or its representatives on an unsolicited basis, and (ii) entered into confidentiality agreements with 22 of those counterparties; |
• | the fact that, on July 9, 2026 and again on August 18, 2026 and October 9, 2026, there were published media reports regarding a potential acquisition of the Company, which provided any third party not otherwise contacted by the Company or its representatives an opportunity to put forward a proposal; |
• | the increase in Parent’s proposed price from $7.35 per share on September 14, 2026 to $7.55 per share on September 18, 2026 and then to $7.75 per share on October 12, 2026, which Parent stated was its “best and final” proposal; |
• | the belief that, in light of the course of negotiations with Parent, $7.75 per share is the highest price that Parent is willing to pay and that the terms of the Merger Agreement include the most favorable terms to the Company, in the aggregate, to which Parent is willing to agree; |
• | the financial analyses of Morgan Stanley reviewed with the Transaction Committee on October 13, 2026, including that the Per Share Price was within the ranges indicated by such analyses, and the fact that Morgan |
TABLE OF CONTENTS
• | the terms and conditions of the Merger Agreement permitting the Company to respond to unsolicited Acquisition Proposals, including permitting the Company to furnish non-public information to, and engage in discussions and negotiations with, a third party that has made an Acquisition Proposal that the Company Board determines in good faith constitutes, or could reasonably be expected to lead to, a Superior Proposal (see the section of this proxy statement titled “The Merger Agreement — No Solicitation of Other Offers”), and the ability of the Company Board, under certain circumstances, to make a Company Board Recommendation Change or to terminate the Merger Agreement to enter into a definitive agreement providing for a Superior Proposal, subject to payment of the Company Termination Fee of $149,520,000 (representing approximately 3.0% of the equity value implied by the Per Share Price), which amount the Transaction Committee believes to be reasonable under the circumstances and unlikely to serve as a meaningful deterrent to other acquisition proposals (see the section of this proxy statement titled “The Merger Agreement — Termination Fees”); |
• | the terms of the Merger Agreement, which were the product of arm’s-length negotiations between the Company and Parent and reflect terms and conditions that are, in the Transaction Committee’s view, advisable and favorable to the Company and Company stockholders, and the likelihood that the Merger would be completed in a timely manner in view of such terms, including: |
• | the limited number and nature of the conditions to Parent’s obligation to consummate the Merger, including that the expiration or termination of the waiting period under the HSR Act is the only regulatory approval condition to the Closing; |
• | the covenants by the parties to use their respective reasonable best efforts to consummate the Closing, Parent’s commitment, subject to certain limitations, to take all actions necessary to obtain the expiration or termination of the applicable waiting period under the HSR Act prior to the Termination Date (as defined in the section of this proxy statement titled “The Merger Agreement — Termination of the Merger Agreement”), including agreeing to divestitures and other remedies with respect to the Company and its subsidiaries (but not with respect to Parent’s affiliates or their respective portfolio companies), and the parties’ assessment of the likelihood of obtaining required regulatory approvals prior to the Termination Date; |
• | Parent’s and Merger Sub’s representations and covenants contained in the Merger Agreement relating to the Financing, the fact that the Merger is not subject to a financing condition and the Company’s entitlement, under certain circumstances pursuant to the Merger Agreement and the Equity Commitment Letters, to specific performance of Parent’s and Merger Sub’s obligations to consummate the Merger and the Guarantors’ obligation to fund the Equity Financing pursuant to the Equity Commitment Letters, and, other than with respect to consummation of the Closing, to specific performance to prevent breaches of, and to enforce specifically the terms of, the Merger Agreement (see the section of this proxy statement titled “The Merger — Financing of the Merger”); |
• | the requirement that, in certain circumstances, Parent is obligated to pay the Company the Parent Termination Fee of $313,992,000 (representing approximately 6.3% of the equity value implied by the Per Share Price), which is guaranteed, severally and not jointly on a pro rata basis, by the GTCR Funds and the Elliott Funds (see the section of this proxy statement titled “The Merger Agreement — Termination Fees”); |
• | the representations, warranties and covenants of the parties, the conditions to the parties’ obligations to complete the Merger and their ability to terminate the Merger Agreement; |
• | the fact that the definition of “Company Material Adverse Effect” has a number of customary exceptions; and |
• | the fact that the Merger Agreement’s restrictions on the Company’s ability to take certain actions during the pendency of the Merger will not unduly interfere with the Company’s ability to operate its business in the ordinary course between the execution of the Merger Agreement and the consummation of the Merger; |
• | the fact that the Merger is subject to the Requisite Stockholder Approval, and that Company stockholders are free to vote for or against the Merger Proposal; |
TABLE OF CONTENTS
• | the fact that appraisal rights are available to Company stockholders who properly exercise their statutory rights under Section 262 of the DGCL (see the section of this proxy statement titled “Appraisal Rights”); |
• | the fact that the Company’s legal and financial advisors were involved throughout the process and negotiations and updated the Transaction Committee directly and regularly, thereby providing the Transaction Committee with additional perspectives on the negotiations; and |
• | the fact that the termination date of April 14, 2027 is expected to allow for sufficient time to complete the Merger. |
• | that, following the completion of the Merger, the Company will no longer exist as an independent public company and that the consummation of the Merger and receipt of the Per Share Price, while providing certainty of value, will not allow Company stockholders (other than, indirectly, the Rollover Investors with respect to their equity interests in Topco) to participate in potential further growth in the Company’s assets, future earnings growth or future appreciation in value of Company Common Stock, including the possibility that the trading price or value of Company Common Stock might in the future have exceeded the Per Share Price; |
• | the risk that the Transactions, including the Merger, may not be consummated in a timely manner or at all, and the consequences thereof, including (a) the potential loss of value to Company stockholders, (b) the potential negative impact on the business, operations, financial results, stock price and prospects of the Company, and (c) the potential adverse effect on the market’s perception of the Company’s prospects if such transactions were delayed or were not consummated; |
• | the risk that, while the Merger is expected to be completed, there can be no guarantee that all conditions to the parties’ obligations to complete the Merger will be satisfied, and as a result, it is possible that the Merger may not be completed even if approved by Company stockholders at the Special Meeting; |
• | the possible negative effects of the public announcement of the Merger on the Company’s sales, operating results and stock price, its ability to retain key management, sales, engineering and other personnel and its relationships with customers and partners; |
• | the significant costs involved in connection with negotiating the Merger Agreement and completing the Merger (including certain costs and expenses if the Merger is not consummated), the substantial management time and effort required to effectuate the Merger and the related disruption to the Company’s day-to-day operations during the pendency of the Merger; |
• | that the terms of the Merger Agreement place restrictions on the conduct of the Company’s business prior to completion of the Merger, which may delay or prevent the Company from undertaking business opportunities that may arise pending completion of the Merger, and the resultant risk if the Merger is not consummated; |
• | the restrictions imposed by the Merger Agreement on the Company’s solicitation of acquisition proposals from third parties and that potential bidders may perceive Parent’s right under the Merger Agreement to negotiate with the Company to match the terms of any acquisition proposal prior to the Company being able to terminate the Merger Agreement and accept an acquisition proposal to be a deterrent to making alternative proposals, and the possibility that the Company may be obligated to pay Parent the Company Termination Fee of $149,520,000 upon the termination of the Merger Agreement under certain circumstances; |
• | the fact that, in certain circumstances, the Company’s remedies are limited to the Parent Termination Fee of $313,992,000, plus Enforcement Costs of up to $7,500,000 and certain Reimbursement Obligations, which may be inadequate to compensate the Company, and that the Company’s right to specific performance of Parent’s obligation to close is conditioned on, among other things, the Debt Financing having been funded or being funded at the Closing; |
• | the possible effects of the pendency or consummation of the transactions contemplated by the Merger Agreement, including the potential for suits, actions or proceedings in respect of the Merger Agreement or the Transactions, including the Merger; |
TABLE OF CONTENTS
• | the fact that the Per Share Price consists of cash and will therefore be taxable to Company stockholders who are subject to taxation for U.S. federal income tax purposes; and |
• | the fact that certain directors and executive officers have interests in the Merger that differ from, or are in addition to, those of Company stockholders generally, including (i) the issuance of SPAC Merger Earnout Shares to certain directors and officers of the Company (and/or their affiliates), which is triggered by the Merger as a “Change in Control” under the SPAC Merger Agreement, (ii) the Rollover Agreements entered into by Mr. Ramamurthy, the Company’s Chairman and Chief Executive Officer (and his affiliated entity), and Mr. Welsh, the Company’s President, and (iii) the treatment of equity awards, 2026 annual bonuses and severance and other compensation arrangements, each as described in the section of this proxy statement titled “The Merger — Interests of the Company’s Directors and Executive Officers in the Merger.” |
• | that the Transaction Committee consists solely of directors who are disinterested with respect to the Company Earnout Shares and the Rollover Agreements; |
• | the power and authority delegated to the Transaction Committee by the Company Board, in accordance with Section 144(a) of the DGCL, with respect to evaluating and determining whether the Merger, including the Per Share Price, is fair to and in the best interests of Company stockholders who are neither entitled to receive Company Earnout Shares nor party to the Rollover Agreements, and making a recommendation to the Company Board with respect thereto; |
• | the fact that the Company Board resolved that it would not approve a potential sale of the Company without a favorable recommendation by the Transaction Committee, and that the Company Board approved the Merger Agreement only after receiving the Transaction Committee’s unanimous recommendation; |
• | the recognition by the Transaction Committee that it had no obligation to recommend the Merger Agreement or any other transaction to the Company Board; |
• | that the Transaction Committee met regularly to discuss and evaluate the overall transaction process as well as the Merger, and its members were actively engaged in the process; and |
• | that the Transaction Committee made its evaluation with full knowledge of the interests of the holders of Company Earnout Shares and of the Rollover Investors in the Merger. |
TABLE OF CONTENTS
• | the Transaction Committee’s analysis (as to both the substantive and procedural aspects of the Merger), conclusions and determination that the Transactions and the terms and conditions of the Merger, including the Per Share Price payable to Company stockholders, are fair to, and in the best interests of, the Company and the Company stockholders who are neither entitled to receive Company Earnout Shares nor party to the Rollover Agreements, and its unanimous recommendation that the Company Board (i) approve, adopt and authorize the Transactions, the Merger Agreement and the transactions contemplated thereby, (ii) direct the Company to enter into and deliver the Merger Agreement and any related documents required to be delivered in connection therewith and (iii) recommend that the Company stockholders vote to adopt the Merger Agreement and approve the Merger, the Merger Agreement and the transactions contemplated thereby, without which the Company Board had resolved it would not approve a potential sale of the Company; |
• | the fact that the Per Share Price of $7.75 is all cash, which provides certainty, immediate value and liquidity to Company stockholders (other than the Rollover Investors, with respect to the shares of Company Common Stock to be contributed to Topco pursuant to the Rollover Agreements) upon consummation of the Merger, while eliminating exposure to business and execution risk, compared to continuing to operate the Company as a standalone company; |
• | the historical market prices, volatility and trading information with respect to Company Common Stock, including the fact that $7.75 per share to be received by Company stockholders represents a premium of approximately (a) 44% over the unaffected closing price of Company Common Stock of $5.38 on July 9, 2026, the last full trading day prior to the publication of market rumors regarding a potential acquisition of the Company, (b) 59% over the unaffected 30-trading day volume-weighted average price of Company Common Stock of $4.87 as of the last full trading day prior to the publication of market rumors regarding a potential acquisition of the Company and (c) 48% over the unaffected 90-trading day average price of Company Common Stock of $5.24 as of the last full trading day prior to the publication of market rumors regarding a potential acquisition of the Company; |
• | the belief that the Per Share Price of $7.75 is more favorable to Company stockholders on a risk-adjusted basis than the potential value that might result from other alternatives reasonably available to the Company, including continuing as an independent public company, based upon the Company Board members’ knowledge of the Company’s business, assets, financial condition and results of operations as well as the industry in which the Company operates, the execution challenges that the Company potentially faces and general market dynamics, and taking into account: |
• | the Company’s historical and projected financial performance, including the Projections described in the section of this proxy statement titled “The Merger — Certain Company Management Projections,” and the fact that the full realization of the Projections was subject to significant execution risk; |
• | the challenges and risks that the Company has faced, and would likely continue to face, if it remained an independent public company, including, among other things, the need for further proof points for the Company’s AI-led growth, the need to adopt and integrate evolving technologies, including AI, the possibility that advanced driver-assistance systems and other vehicle technology could reduce accident frequency, the Company’s concentration among insurance carrier customers, the competitive landscape, financial and execution risks associated with the Company’s standalone plan, and the potential impact of those factors on the trading price of Company Common Stock (which cannot be quantified numerically); |
TABLE OF CONTENTS
• | the impact and status of general industry, economic and market conditions and trends relevant to the Company’s business, including information regarding recent AI-related developments affecting software companies more broadly and the potential impact that advancements in AI could have on the Company’s industry and long-term business prospects, and, in light of such conditions and trends, the risks and challenges to value creation associated with continuing to operate the Company as a standalone public company; and |
• | the risk that, absent the Merger, the trading price of Company Common Stock would not achieve a value comparable to the Per Share Price within a reasonable timeframe, including due to the potential negative impact of stock market disruptions relating to advancements in AI on the relative trading performance of software businesses or, more generally, recent market volatility; |
• | the sale process conducted by the Company, with the assistance of Morgan Stanley and Kirkland, including that the Company (i) discussed possible interest in a potential transaction with 39 potential counterparties (consisting of 31 financial sponsors and 8 strategic parties), of which 22 were contacted by Morgan Stanley at the direction of the Company and 17 contacted the Company or its representatives on an unsolicited basis, and (ii) entered into confidentiality agreements with 22 of those counterparties; |
• | the fact that, on July 9, 2026 and again on August 18, 2026 and October 9, 2026, there were published media reports regarding a potential acquisition of the Company, which provided any third party not otherwise contacted by the Company or its representatives an opportunity to put forward a proposal; |
• | the increase in Parent’s proposed price from $7.35 per share on September 14, 2026 to $7.55 per share on September 18, 2026 and then to $7.75 per share on October 12, 2026, which Parent stated was its “best and final” proposal; |
• | the belief that, in light of the course of negotiations with Parent, $7.75 per share is the highest price that Parent is willing to pay and that the terms of the Merger Agreement include the most favorable terms to the Company, in the aggregate, to which Parent is willing to agree; |
• | the oral opinion of Morgan Stanley rendered to the Company Board on October 14, 2026, which was subsequently confirmed by delivery of a written opinion, as to whether, as of its date and subject to the assumptions, limitations, qualifications and other matters stated in it, the Per Share Price to be paid to the holders of Company Common Stock (other than holders of Owned Company Shares, Dissenting Company Shares or Company RSAs) was fair, from a financial point of view, to such holders (see the section of this proxy statement titled “The Merger — Opinion of the Company Financial Advisor”); |
• | the terms and conditions of the Merger Agreement permitting the Company to respond to unsolicited Acquisition Proposals, including permitting the Company to furnish non-public information to, and engage in discussions and negotiations with, a third party that has made an Acquisition Proposal that the Company Board determines in good faith constitutes, or could reasonably be expected to lead to, a Superior Proposal (see the section of this proxy statement titled “The Merger Agreement — No Solicitation of Other Offers”), and the ability of the Company Board, under certain circumstances, to make a Company Board Recommendation Change or to terminate the Merger Agreement to enter into a definitive agreement providing for a Superior Proposal, subject to payment of the Company Termination Fee of $149,520,000 (representing approximately 3.0% of the equity value implied by the Per Share Price) (see the section of this proxy statement titled “The Merger Agreement — Termination Fees”); |
• | the terms of the Merger Agreement, which were the product of arm’s-length negotiations between the Company and Parent and reflect terms and conditions that are, in the Company Board’s view, advisable and favorable to the Company and Company stockholders, and the likelihood that the Merger would be completed in a timely manner in view of such terms, including: |
• | the limited number and nature of the conditions to Parent’s obligation to consummate the Merger, including that the expiration or termination of the waiting period under the HSR Act is the only regulatory approval condition to the Closing; |
• | the covenants by the parties to use their respective reasonable best efforts to consummate the Closing, Parent’s commitment, subject to certain limitations, to take all actions necessary to obtain the expiration or termination of the applicable waiting period under the HSR Act prior to the Termination Date (as defined in the section of this proxy statement titled “The Merger Agreement — Termination of the Merger Agreement”), |
TABLE OF CONTENTS
• | Parent’s and Merger Sub’s representations and covenants contained in the Merger Agreement relating to the Financing, the fact that the Merger is not subject to a financing condition and the Company’s entitlement, under certain circumstances pursuant to the Merger Agreement and the Equity Commitment Letters, to specific performance of Parent’s and Merger Sub’s obligations to consummate the Merger and the Guarantors’ obligation to fund the Equity Financing pursuant to the Equity Commitment Letters, and, other than with respect to consummation of the Closing, to specific performance to prevent breaches of, and to enforce specifically the terms of, the Merger Agreement (see the section of this proxy statement titled “The Merger — Financing of the Merger”); |
• | the requirement that, in certain circumstances, Parent is obligated to pay the Company the Parent Termination Fee of $313,992,000 (representing approximately 6.3% of the equity value implied by the Per Share Price), which is guaranteed, severally and not jointly on a pro rata basis, by the GTCR Funds and the Elliott Funds (see the section of this proxy statement titled “The Merger Agreement — Termination Fees”); |
• | the representations, warranties and covenants of the parties, the conditions to the parties’ obligations to complete the Merger and their ability to terminate the Merger Agreement; |
• | the fact that the definition of “Company Material Adverse Effect” has a number of customary exceptions; and |
• | the fact that the Merger Agreement’s restrictions on the Company’s ability to take certain actions during the pendency of the Merger will not unduly interfere with the Company’s ability to operate its business in the ordinary course between the execution of the Merger Agreement and the consummation of the Merger; |
• | the fact that the Merger is subject to the Requisite Stockholder Approval, and that Company stockholders are free to vote for or against the Merger Proposal; |
• | the fact that appraisal rights are available to Company stockholders who properly exercise their statutory rights under Section 262 of the DGCL (see the section of this proxy statement titled “Appraisal Rights”); and |
• | the procedural fairness of the Merger, including that (i) the Transaction Committee consists solely of directors who are disinterested with respect to the Company Earnout Shares and the Rollover Agreements, (ii) the Transaction Committee was delegated the power and authority of the Company Board, in accordance with Section 144(a) of the DGCL, with respect to evaluating and determining whether the Merger, including the Per Share Price, is fair to and in the best interests of Company stockholders who are neither entitled to receive Company Earnout Shares nor party to the Rollover Agreements, and making a recommendation to the Company Board with respect thereto, (iii) the Company Board resolved that it would not approve a potential sale of the Company without a favorable recommendation by the Transaction Committee, (iv) the Transaction Committee recognized that it had no obligation to recommend the Merger Agreement or any other transaction to the Company Board, (v) the Transaction Committee held six meetings to discuss and evaluate the Merger, and its members were actively engaged in the process, and (vi) the Transaction Committee made its evaluation with full knowledge of the interests of the holders of Company Earnout Shares and of the Rollover Investors in the Merger. |
• | that, following the completion of the Merger, the Company will no longer exist as an independent public company and that the consummation of the Merger and receipt of the Per Share Price, while providing certainty of value, will not allow Company stockholders (other than, indirectly, the Rollover Investors with respect to their equity interests in Topco) to participate in potential further growth in the Company’s assets, future earnings growth or future appreciation in value of Company Common Stock, including the possibility that the trading price or value of Company Common Stock might in the future have exceeded the Per Share Price; |
TABLE OF CONTENTS
• | the risk that the Transactions, including the Merger, may not be consummated in a timely manner or at all, and the consequences thereof, including (a) the potential loss of value to Company stockholders, (b) the potential negative impact on the business, operations, financial results, stock price and prospects of the Company, and (c) the potential adverse effect on the market’s perception of the Company’s prospects if such transactions were delayed or were not consummated; |
• | the risk that, while the Merger is expected to be completed, there can be no guarantee that all conditions to the parties’ obligations to complete the Merger will be satisfied, and as a result, it is possible that the Merger may not be completed even if approved by Company stockholders at the Special Meeting; |
• | the possible negative effects of the public announcement of the Merger on the Company’s sales, operating results and stock price, its ability to retain key management, sales, engineering and other personnel and its relationships with customers and partners; |
• | the significant costs involved in connection with negotiating the Merger Agreement and completing the Merger (including certain costs and expenses if the Merger is not consummated), the substantial management time and effort required to effectuate the Merger and the related disruption to the Company’s day-to-day operations during the pendency of the Merger; |
• | that the terms of the Merger Agreement place restrictions on the conduct of the Company’s business prior to completion of the Merger, which may delay or prevent the Company from undertaking business opportunities that may arise pending completion of the Merger, and the resultant risk if the Merger is not consummated; |
• | the restrictions imposed by the Merger Agreement on the Company’s solicitation of acquisition proposals from third parties and that potential bidders may perceive Parent’s right under the Merger Agreement to negotiate with the Company to match the terms of any acquisition proposal prior to the Company being able to terminate the Merger Agreement and accept an acquisition proposal to be a deterrent to making alternative proposals, and the possibility that the Company may be obligated to pay Parent the Company Termination Fee of $149,520,000 upon the termination of the Merger Agreement under certain circumstances; |
• | the fact that, in certain circumstances, the Company’s remedies are limited to the Parent Termination Fee of $313,992,000, plus Enforcement Costs of up to $7,500,000 and certain Reimbursement Obligations, which may be inadequate to compensate the Company, and that the Company’s right to specific performance of Parent’s obligation to close is conditioned on, among other things, the Debt Financing having been funded or being funded at the Closing; |
• | the possible effects of the pendency or consummation of the transactions contemplated by the Merger Agreement, including the potential for suits, actions or proceedings in respect of the Merger Agreement or the Transactions, including the Merger; |
• | the fact that the Per Share Price consists of cash and will therefore be taxable to Company stockholders who are subject to taxation for U.S. federal income tax purposes; and |
• | the fact that certain directors and executive officers have interests in the Merger that differ from, or are in addition to, those of Company stockholders generally, including (i) the issuance of SPAC Merger Earnout Shares to certain directors and officers of the Company (and/or their affiliates), which is triggered by the Merger as a “Change in Control” under the SPAC Merger Agreement, (ii) the Rollover Agreements entered into by Mr. Ramamurthy, the Company’s Chairman and Chief Executive Officer (and his affiliated entity), and Mr. Welsh, the Company’s President, and (iii) the treatment of equity awards, 2026 annual bonuses and severance and other compensation arrangements, each as described in the section of this proxy statement titled “The Merger — Interests of the Company’s Directors and Executive Officers in the Merger.” |
TABLE OF CONTENTS
1) | Reviewed certain publicly available financial statements and other business and financial information of the Company; |
2) | Reviewed certain internal financial statements and other financial and operating data concerning the Company; |
3) | Reviewed certain financial projections prepared by the management of the Company; |
4) | Discussed the past and current operations and financial condition and the prospects of the Company with senior executives of the Company; |
5) | Reviewed the reported prices and trading activity for Company Common Stock; |
6) | Compared the financial performance of the Company and the prices and trading activity of Company Common Stock with that of certain other publicly-traded companies comparable with the Company and their securities; |
7) | Reviewed the financial terms, to the extent publicly available, of certain comparable acquisition transactions; |
8) | Participated in certain discussions and negotiations among representatives of the Company and Parent and their financial and legal advisors; |
9) | Reviewed (a) a draft of the Merger Agreement dated October 14, 2026, (b) the draft equity commitment letters and preferred equity commitment letter from certain investors substantially in the forms of the drafts dated October 14, 2026 and October 12, 2026, respectively, the executed Debt Commitment Letter from certain debt financing sources dated October 12, 2026 (collectively, the documents in this clause (b), the |
TABLE OF CONTENTS
10) | Performed such other analyses and considered such other factors as Morgan Stanley deemed appropriate. |
TABLE OF CONTENTS
• | Guidewire Software, Inc. |
• | Bentley Systems, Inc. |
• | Tyler Technologies, Inc. |
• | Verisk Analytics, Inc. |
• | Veeva Systems Inc. |
• | Copart, Inc. |
• | Doximity, Inc. |
• | SS&C Technologies Holdings, Inc. |
• | Blackbaud, Inc. |
• | Salesforce, Inc. |
• | Workday, Inc. |
• | Adobe Inc. |
• | Autodesk, Inc. |
• | Trimble Inc. |
• | FactSet Research Systems Inc. |
• | Dassault Systèmes SE |
• | Waystar Holding Corp. |
• | the ratio of aggregate value (“AV”), defined as market capitalization plus total debt less cash and cash equivalents, to estimated calendar year 2027 revenues; |
• | the ratio of AV to estimated calendar year 2027 unburdened EBITDA (“EBITDA”); and |
• | the ratio of AV to estimated calendar year 2027 unburdened unlevered free cash flow (“UFCF”). |
TABLE OF CONTENTS
Calendar Year Financial Statistic | Comparable Company Multiple Statistic | Implied Value Per Share Range for the Company | ||||
Aggregate Value to Estimated 2027 Revenues (Street Case) | 3.5x - 5.5x | $5.42 - $9.47 | ||||
Aggregate Value to Estimated 2027 Revenues (September Projections) | 3.5x - 5.5x | $5.59 - $9.73 | ||||
Aggregate Value to Estimated 2027 EBITDA (Street Case) | 8.0x - 13.0x | $5.24 - $9.55 | ||||
Aggregate Value to Estimated 2027 EBITDA (September Projections) | 8.0x - 13.0x | $5.57 - $10.07 | ||||
Aggregate Value to Estimated 2027 UFCF (Street Case) | 12.0x - 18.0x | $5.33 - $8.82 | ||||
Aggregate Value to Estimated 2027 UFCF (September Projections) | 12.0x - 18.0x | $5.63 - $9.27 | ||||
TABLE OF CONTENTS
Forecast Scenario | Implied Equity Value Per Share of the Company | ||
September Projections | $6.58 - $9.84 | ||
TABLE OF CONTENTS
Target / Acquiror | Date Announced | AV / NTM EBITDA | ||||
PowerSchool / Bain Capital | June 2024 | 21.0x | ||||
Black Knight / ICE | March 2023 | 19.9x | ||||
Dayforce / Thoma Bravo | August 2025 | 18.4x | ||||
Cornerstone OnDemand / Clearlake Capital | August 2021 | 18.3x | ||||
PTC / Schneider Electric | October 2026 | 18.1x | ||||
McAfee / Advent, Permira, Crosspoint | November 2021 | 17.5x | ||||
Avast / NortonLifeLock | August 2021 | 17.2x | ||||
Citrix / Vista Equity Partners (TIBCO), Evergreen (Elliott) | January 2022 | 16.2x | ||||
Informatica / Salesforce | May 2025 | 15.1x | ||||
Solera / Vista Equity Partners | September 2015 | 13.3x | ||||
CDK / Brookfield | April 2022 | 12.0x | ||||
SolarWinds / Turn/River Capital | February 2025 | 11.6x | ||||
CA Technologies / Broadcom | July 2018 | 10.8x | ||||
LogMeIn / Francisco Partners; Evergreen (Elliott) | December 2019 | 10.6x | ||||
Dun & Bradstreet / Clearlake Capital | March 2025 | 8.0x | ||||
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
Management Case | Extrapolations | |||||||||||||||||||||||||||||
($ in millions) | 2026E | 2027E | 2028E | 2029E | 2030E | 2031E | 2032E | 2033E | 2034E | 2035E | ||||||||||||||||||||
Total Revenue | $1,162 | $1,295 | $1,441 | $1,604 | $1,780 | $1,947 | $2,099 | $2,229 | $2,331 | $2,401 | ||||||||||||||||||||
Unburdened EBITDA(1) | $488 | $564 | $650 | $748 | $857 | $945 | $1,026 | $1,098 | $1,157 | $1,201 | ||||||||||||||||||||
Stock-Based Compensation | ($139) | ($117) | ($130) | ($144) | ($160) | ($163) | ($166) | ($169) | ($172) | ($175) | ||||||||||||||||||||
Burdened EBITDA(2) | $348 | $448 | $520 | $603 | $697 | $782 | $860 | $929 | $985 | $1,026 | ||||||||||||||||||||
Burdened EBIT(3) | $286 | $375 | $446 | $529 | $619 | $696 | $767 | $830 | $881 | $918 | ||||||||||||||||||||
Taxes | ($74) | ($97) | ($116) | ($137) | ($161) | ($181) | ($199) | ($216) | ($229) | ($239) | ||||||||||||||||||||
Depreciation and Amortization | $63 | $73 | $74 | $75 | $78 | $86 | $93 | $99 | $104 | $108 | ||||||||||||||||||||
Capital Expenditures (including Capitalized Software) | ($73) | ($75) | ($76) | ($77) | ($80) | ($87) | ($94) | ($100) | ($105) | ($108) | ||||||||||||||||||||
Change in Net Working Capital | ($9) | ($12) | ($15) | ($16) | ($17) | ($16) | ($14) | ($12) | ($10) | ($7) | ||||||||||||||||||||
Burdened Unlevered Free Cash Flow(4) | $191 | $263 | $313 | $374 | $439 | $497 | $552 | $601 | $642 | $673 | ||||||||||||||||||||
(1) | “Unburdened EBITDA” is a non-GAAP measure calculated as earnings before interest, taxes, depreciation and amortization. |
(2) | “Burdened EBITDA” is a non-GAAP measure calculated as earnings before interest, taxes, depreciation and amortization, burdened by stock-based compensation. |
(3) | “Burdened EBIT” is a non-GAAP measure calculated as earnings before interest and taxes, burdened by stock-based compensation. |
(4) | “Burdened Unlevered Free Cash Flow” is a non-GAAP measure calculated as Burdened EBITDA minus taxes, minus capital expenditures (including capitalized software), and minus changes in net working capital. |
Management Case | Extrapolations | |||||||||||||||||||||||||||||
($ in millions) | 2026E | 2027E | 2028E | 2029E | 2030E | 2031E | 2032E | 2033E | 2034E | 2035E | ||||||||||||||||||||
Total Revenue | $1,162 | $1,295 | $1,441 | $1,604 | $1,780 | $1,947 | $2,098 | $2,228 | $2,330 | $2,400 | ||||||||||||||||||||
Unburdened EBITDA(1) | $494 | $564 | $650 | $748 | $857 | $944 | $1,026 | $1,097 | $1,156 | $1,200 | ||||||||||||||||||||
Stock-Based Compensation | ($131) | ($117) | ($130) | ($144) | ($160) | ($163) | ($166) | ($169) | ($172) | ($175) | ||||||||||||||||||||
Burdened EBITDA(2) | $363 | $448 | $520 | $604 | $697 | $781 | $860 | $928 | $984 | $1,025 | ||||||||||||||||||||
Burdened EBIT(3) | $302 | $375 | $446 | $529 | $619 | $696 | $767 | $829 | $880 | $917 | ||||||||||||||||||||
Taxes | ($79) | ($97) | ($116) | ($138) | ($161) | ($181) | ($199) | ($216) | ($229) | ($238) | ||||||||||||||||||||
TABLE OF CONTENTS
Management Case | Extrapolations | |||||||||||||||||||||||||||||
($ in millions) | 2026E | 2027E | 2028E | 2029E | 2030E | 2031E | 2032E | 2033E | 2034E | 2035E | ||||||||||||||||||||
Depreciation and Amortization | $61 | $73 | $74 | $75 | $78 | $86 | $93 | $99 | $104 | $108 | ||||||||||||||||||||
Capital Expenditures (including Capitalized Software) | ($75) | ($75) | ($76) | ($77) | ($80) | ($87) | ($94) | ($100) | ($105) | ($108) | ||||||||||||||||||||
Change in Net Working Capital | ($9) | ($12) | ($15) | ($16) | ($17) | ($16) | ($14) | ($12) | ($10) | ($7) | ||||||||||||||||||||
Burdened Unlevered Free Cash Flow(4) | $200 | $263 | $313 | $374 | $439 | $497 | $552 | $600 | $641 | $672 | ||||||||||||||||||||
(1) | “Unburdened EBITDA” is a non-GAAP measure calculated as earnings before interest, taxes, depreciation and amortization. |
(2) | “Burdened EBITDA” is a non-GAAP measure calculated as earnings before interest, taxes, depreciation and amortization, burdened by stock-based compensation. |
(3) | “Burdened EBIT” is a non-GAAP measure calculated as earnings before interest and taxes, burdened by stock-based compensation. |
(4) | “Burdened Unlevered Free Cash Flow” is a non-GAAP measure calculated as Burdened EBITDA minus taxes, minus capital expenditures (including capitalized software), and minus changes in net working capital. |
TABLE OF CONTENTS
• | Consolidated revenue growth at a compound annual growth rate of approximately 11% from fiscal year 2025 through fiscal year 2030, driven by (i) growth in the Company’s insurance business reflecting increased adoption of AI-enabled solutions among existing customers, including broader deployment of Intelligent Estimating, First Look and Intelligent Reinspection solutions, together with modest growth in core Auto Physical Damage solutions; (ii) additional insurance revenue growth from (a) the expansion of EvolutionIQ’s solutions through new customer additions and cross-selling opportunities within the Company’s existing insurance customer base; and (b) increased adoption of the Company’s casualty and subrogation solutions; and (iii) growth in the Company’s automotive business driven by new repair facility customers, increased upsell of packaged solutions and adoption of add-on solutions, and increased growth in the expansion of the supplier networks; |
• | Gross profit and Burdened EBITDA margin expansion reflecting anticipated operating leverage as revenue grows, with operating expenses declining as a percentage of revenue while maintaining continued investment in product development; |
• | Stock-based compensation expense declining as a percentage of revenue, reaching approximately $160 million in fiscal year 2030; |
• | A tax rate of 26% (including federal, state and local taxes) throughout the periods covered by the Projections; and |
• | Growth in Burdened Unlevered Free Cash Flow reflecting anticipated improvements in operating profitability. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
SPAC Merger Earnout Shares | Value of SPAC Merger Earnout Shares ($) | |||||
Executive Officers | ||||||
Githesh Ramamurthy | 1,298,389 | 10,062,515 | ||||
Tim Welsh | — | |||||
Rodney Christo | 21,647 | 167,764 | ||||
Joshua Valdez | — | — | ||||
Brian Herb | 9,064 | 70,246 | ||||
Mary Jo Prigge | 22,707 | 175,979 | ||||
John Goodson | — | — | ||||
Marc Fredman | 75,404 | 584,381 | ||||
Non-Employee Directors | ||||||
Eric Wei(1) | 9,919,012 | 76,872,343 | ||||
William Ingram | 7,698 | 59,660 | ||||
Teri Williams | 7,698 | 59,660 | ||||
Eileen Schloss | 7,698 | 59,660 | ||||
Barak Eilam | — | — | ||||
John Schweitzer | — | — | ||||
Neil de Crescenzo | — | — | ||||
Lauren Young(1)(2) | 9,919,012 | 76,872,343 | ||||
(1) | The SPAC Merger Earnout Shares set forth in the table are held of record by Cypress Investor Holdings, L.P. (“Cypress Investor”), GPE VIII CCC Co-Investment (Delaware) Limited Partnership (“GPE VIII CCC Co-Investment”) and Advent International GPE VIII-C Limited Partnership (“Advent International VIII-C”). Based on the Company’s records and a Schedule 13D/A filed with the SEC on August 7, 2025, (a) Cypress Investment GP, LLC (“Cypress GP”) is the general partner of Cypress Investor, Advent International, L.P. (“Advent”) is the managing member of Cypress GP and Advent International GP, LLC (“Advent GP LLC”) is the general partner of Advent, (b) GPE VIII GP S.a.r.l (“Advent GP Luxembourg”) is the general partner of Advent International VIII-C, Advent International GPE VIII, LLC (“Advent VIII GP”) is the manager of Advent GP Luxembourg and Advent is the manager of Advent VIII GP and (c) GPE VIII GP Limited Partnership (“Advent GP Cayman”) is the general partner of GPE VIII CCC Co-Investment, Advent VIII GP is the general partner of Advent GP Cayman and Advent is the manager of Advent VIII GP. Mr. Wei is a Managing Partner of Advent and may have limited partner or other interests in one or more of the entities described herein. Ms. Young is a Managing Director of Advent and may have limited partner or other interests in one or more of the entities described herein. |
(2) | The SPAC Merger Earnout Shares and related value reported for Ms. Young are the same SPAC Merger Earnout Shares and related value reported for Mr. Wei, which are held of record by the Advent entities described in footnote (1), and are not in addition to them. |
TABLE OF CONTENTS
TABLE OF CONTENTS
Named Executive Officer | Cash ($)(1) | Equity ($)(2) | Total ($) | ||||||
Githesh Ramamurthy | 1,930,837 | — | 1,930,837 | ||||||
Timothy A. Welsh | 1,043,498 | 9,026,487 | 10,069,985 | ||||||
Brian Herb | — | — | — | ||||||
Mary Jo Prigge | — | 490,513 | 490,513 | ||||||
John Goodson | — | — | — | ||||||
(1) | Cash. For Mr. Ramamurthy, consists of (i) continued monthly payments, for 24 months, each equal to one-twelfth of the sum of his annual base salary and target annual bonus (which is currently 0% of his annual base salary); (ii) a lump sum cash payment equal to a pro rata portion of the annual performance-based cash bonus he would have earned for the year of termination, shown in the table above at target level; and (iii) a cash payment equal to the portion of the monthly COBRA premium for continued health coverage that the Company pays for active employees, for 24 months, regardless of whether Mr. Ramamurthy is legally entitled to COBRA benefits during such period. For Mr. Welsh, consists of (i) continued payment of his annual base salary for 12 months; (ii) a lump sum cash payment equal to the annual performance-based cash bonus, if any, that he would have earned for the year of termination based on actual performance had he remained employed through the bonus payment date, shown in the table above at target level; and (iii) a cash payment equal to the monthly COBRA premium for continued health coverage for 12 months, regardless of whether Mr. Welsh is legally entitled to COBRA benefits during such period. These severance payments are not “single-trigger” or “double-trigger” arrangements. They would be payable on a qualifying termination of employment whether or not in connection with the Merger. Brian Herb, Mary Jo Prigge and John Goodson were named executive officers for fiscal year 2025, but each ceased to be employed by the Company on May 25, 2026, June 6, 2025 and October 10, 2025, respectively, and thus no longer have any severance entitlements. Set forth below are the separate values of each of the severance payments. |
TABLE OF CONTENTS
Named Executive Officer | Severance ($) | Prorated Bonus ($) | COBRA Payment ($) | Total ($) | ||||||||
Githesh Ramamurthy | 1,900,000 | — | 30,837 | 1,930,837 | ||||||||
Timothy A. Welsh | 725,000 | 317,808 | 690 | 1,043,498 | ||||||||
Brian Herb | — | — | — | — | ||||||||
Mary Jo Prigge | — | — | — | — | ||||||||
John Goodson | — | — | — | — | ||||||||
(2) | Equity. Consists of the value of the named executive officer’s Unvested Company RSUs and Unvested Company PSUs, which will be converted at the Effective Time into Company RSU Restricted Cash Awards and Company PSU Restricted Cash Awards, respectively, and which would vest on a qualifying termination of employment following the Effective Time. Amounts are calculated by multiplying the number of shares of Company Common Stock subject to each award by the Per Share Price of $7.75. For the Unvested Company PSUs, the number of shares is determined based on target performance. For Mr. Welsh, this accelerated vesting is a “double-trigger” benefit: it applies only if the named executive officer has a qualifying termination of employment following the Effective Time, as described under “— Treatment of the Company’s Equity Awards” above. Messrs. Ramamurthy, Herb, and Goodson do not hold any Unvested Company PSUs. In connection with Ms. Prigge’s termination of employment, her outstanding Unvested Company PSUs were amended to provide that, in consideration of her executing, and not revoking, a release of claims, the Unvested Company PSUs would remain outstanding and eligible to vest in accordance with the terms of the applicable agreement governing the Unvested Company PSUs, irrespective of her termination of employment. The table below excludes any amounts associated with Company RSUs or Company PSUs that are scheduled to vest in accordance with their terms on or prior to November 17, 2026, the assumed date of the effective time of the Merger solely for purposes of the disclosure, irrespective of the Merger. None of the Company Options held by any named executive officers are unvested as of the date of this proxy statement; accordingly, no amounts are reflected in the table below with respect to Company Options. |
Named Executive Officer | Company RSUs ($) | Company PSUs ($) | Total ($) | ||||||
Githesh Ramamurthy | — | — | — | ||||||
Timothy A. Welsh | 4,192,471 | 4,834,016 | 9,026,487 | ||||||
Brian Herb | — | — | — | ||||||
Mary Jo Prigge | — | 490,513 | 490,513 | ||||||
John Goodson | — | — | — | ||||||
TABLE OF CONTENTS
• | an individual who is a citizen or resident of the United States; |
• | a corporation (including any entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any State thereof or the District of Columbia; |
• | a trust if (a) its administration is subject to the primary supervision of a court within the United States and one or more United States persons as described in Section 7701(a)(30) of the Code have the authority to control all substantial decisions of the trust or (b) it has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a United States person (within the meaning of the Code); and |
• | an estate, the income of which is subject to U.S. federal income tax regardless of its source. |
TABLE OF CONTENTS
• | the gain is effectively connected with the conduct of a U.S. trade or business of such non-U.S. holder (and, if required by an applicable income tax treaty, is also attributable to a permanent establishment or, in the case of an individual, a fixed base in the United States maintained by such non-U.S. holder), in which case the non-U.S. holder will generally be subject to tax on such gain in the same manner as a U.S. holder and, if the non-U.S. holder is a foreign corporation, such corporation may be subject to branch profits tax at the rate of 30% (or such lower rate as may be specified by an applicable income tax treaty) on earnings and profits (as determined for U.S. federal income tax purposes) effectively connected with a U.S. trade or business, subject to certain adjustments; |
• | the non-U.S. holder is a nonresident alien individual who is present in the United States for 183 days or more in the taxable year of the Merger, and certain other conditions are met, in which case the non-U.S. holder will generally be subject to a 30% tax (or tax at such lower rate as may be specified under an applicable income tax treaty) on any gain realized, which may be offset by certain U.S.-source capital losses of the non-U.S. holder, if any, provided that such non-U.S. holder has timely filed U.S. federal income tax returns with respect to such losses; or |
• | the Company is or has been a “United States real property holding corporation” for U.S. federal income tax purposes (a “USRPHC”) at any time during the shorter of (a) the five-year period ending on the date of the Merger and (b) the non-U.S. holder’s holding period in Company Common Stock (such period described in clause (a) and (b), the “Relevant Period”), and, if Company Common Stock is regularly traded on an established securities market (within the meaning of Section 897(c)(3) of the Code), the non-U.S. holder owned (directly, indirectly or constructively) more than 5% of the outstanding Company Common Stock at any time during such Relevant Period. Generally, a corporation is a USRPHC if the fair market value of its United States real property interests (as defined in the Code) equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests plus its other assets used or held for use in a trade or business. Although there can be no assurances in this regard, the Company believes that it is not, and has not been, a USRPHC at any time during the five-year period ending on the date of the Merger. Non-U.S. holders should consult their own tax advisors regarding the possible consequences to them if the Company is a USRPHC. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | due organization, valid existence, good standing and authority and qualification to conduct business with respect to the Company and each of its subsidiaries; |
• | the Company’s corporate power and authority to enter into and perform its obligations under the Merger Agreement and the enforceability of the Merger Agreement; |
• | the necessary approval of the Company Board, receipt of a fairness opinion from Morgan Stanley and the inapplicability to the Merger of Section 203 of the DGCL, Article XII, Section 2 of the certificate of incorporation of the Company and any other similar anti-takeover statutes, regulations or provisions; |
• | required consents, approvals and regulatory filings in connection with the Merger Agreement and performance of the Company’s obligations thereunder; |
• | the absence of conflicts with laws, organizational documents and material contracts of the Company and its subsidiaries; |
• | the capital structure of the Company and its subsidiaries; |
• | compliance with SEC rules regarding filings and financial statements; |
• | disclosure controls and procedures; |
• | internal accounting controls and procedures; |
• | the absence of specified undisclosed liabilities; |
• | absence of certain changes; |
• | the existence and enforceability of specified categories of the Company’s and its subsidiaries’ material contracts, any notices with respect to termination or non-renewal, or disputes with respect to, such material contracts, and the performance by the Company and its subsidiaries in all material respects of their respective obligations under such material contracts; |
• | certain stockholder and management arrangements; |
• | real property owned or leased by the Company and its subsidiaries; |
• | environmental matters; |
• | intellectual property matters; |
• | data protection matters; |
• | tax matters; |
• | employee benefit plans; |
• | labor matters; |
• | compliance with laws; |
• | the absence of pending and threatened litigation and orders; |
• | insurance matters; |
• | anti-corruption, anti-money laundering and sanctions compliance; |
• | the absence of any investment banker, broker, finder or other financial intermediary, other than Morgan Stanley, that has been retained by or is authorized to act on behalf of the Company or any of its subsidiaries who will be entitled to any fee or commission from the Company or any of its subsidiaries in connection with the Transactions; |
• | accuracy of information provided in this proxy statement; |
• | related party transactions; |
TABLE OF CONTENTS
• | government contracts; |
• | customer contracts; |
• | vendor contracts; and |
• | the exclusivity and terms of the representations and warranties made by the Company, Parent and Merger Sub. |
• | due organization, valid existence, good standing and authority and qualification to conduct business with respect to Parent and Merger Sub; |
• | Parent’s and Merger Sub’s corporate power and authority to enter into and perform their respective obligations under the Merger Agreement and the enforceability of the Merger Agreement; |
• | the necessary approval of the board of directors or similar governing body of each of Parent and Merger Sub; |
• | the absence of conflicts with laws, organizational documents and material contracts; |
• | required consents, approvals and regulatory filings in connection with the Merger Agreement and the performance by Parent and Merger Sub of their respective obligations thereunder; |
• | the absence of pending and threatened litigation and orders; |
• | ownership of Company Common Stock; |
• | the absence of any investment banker, broker, finder or other financial intermediary that has been retained by or is authorized to act on behalf of Parent or any of its subsidiaries who will be entitled to any fee or commission from the Company in connection with the transactions contemplated by the Merger Agreement; |
• | operations of Parent and Merger Sub; |
• | the absence of a requirement for a vote or approval of the stockholders of Parent; |
• | delivery and enforceability of the Limited Guarantees; |
• | delivery, validity and sufficiency of the Financing Letters (as defined in the Merger Agreement), including the Equity Commitment Letters and the Debt Commitment Letter (as well as any fee letters related thereto); |
• | solvency of the surviving corporation and its subsidiaries; |
• | accuracy of information provided in this proxy statement; and |
• | the exclusivity and terms of the representations and warranties made by the Company, Parent and Merger Sub. |
(i) | any general economic conditions, or conditions in the global, international or regional economy generally; |
(ii) | any conditions in the equity, credit, debt, financial, banking, currency or capital markets, including (A) changes in interest rates or credit ratings; (B) changes in exchange rates for the currencies of any country; or (C) any suspension of trading in securities (whether equity, debt, derivative or hybrid securities) generally on any securities exchange or over-the-counter market; |
TABLE OF CONTENTS
(iii) | any general conditions in the industries in which the Company and its subsidiaries conduct business or in any jurisdiction or geographical area in which the Company and its subsidiaries conduct business, or changes therein; |
(iv) | any political or geopolitical conditions, outbreak of hostilities, armed conflicts, acts of war (whether or not declared), rebellion, insurrection, sabotage, cyberattack, cyberterrorism, terrorism or military actions, including any escalation or worsening of, or any law or sanction, mandate, directive or pronouncement issued by a governmental authority after the date of the Merger Agreement in response to, the foregoing or any threats thereof, in each case, in the United States or any other country or region in the world; |
(v) | any earthquakes, volcanic activity, hurricanes, tsunamis, tornadoes, floods, mudslides, wildfires, nuclear incidents, foreign or domestic social protest or social unrest (whether or not violent) or other natural or man-made disasters, weather conditions, power outages or electrical black-outs, and other force majeure events, including any escalation or worsening of, or any law or sanction, mandate, directive, pronouncement, guideline or recommendation issued by a governmental authority in response to, any of the foregoing, in each case, in the United States or any other country or region in the world; |
(vi) | the negotiation, execution, delivery or performance of the Merger Agreement or the announcement of the Merger Agreement or the pendency of the Merger or the other Transactions, including the impact thereof on the relationships, contractual or otherwise, of the Company and its subsidiaries with customers, suppliers, lenders, lessors, business or joint venture partners, officers, employees (including any employee departure or attrition), regulators, governmental authorities, vendors or any other third person (it being understood that this clause (vi) will not apply with respect to any representation, warranty or condition to Closing that is intended to address the consequences of the execution and delivery of the Merger Agreement); |
(vii) | the compliance by any party with the express terms of the Merger Agreement, including any action taken or refrained from being taken pursuant to or in accordance with the express terms of the Merger Agreement or any action taken or refrained from being taken to which Parent has expressly approved or consented to in writing (including by email) following the date of the Merger Agreement; |
(viii) | changes or proposed changes in GAAP or other accounting standards, or in any applicable laws (or the enforcement or interpretation of any of the foregoing) or in any regulatory or legislative conditions, including the adoption, implementation, repeal, modification, reinterpretation or proposal of any law, regulation or policy (or the enforcement or interpretation thereof) by any governmental authority, or any panel or advisory body empowered or appointed thereby, in each case, after the date of the Merger Agreement; |
(ix) | any epidemics, pandemics, plagues, other outbreaks of illness or public health events (including quarantine restrictions mandated or recommended by any governmental authority in response to any of the foregoing), including any escalation or worsening of any of the foregoing, in each case, in the United States or any other country or region in the world; |
(x) | any anti-dumping actions, international tariffs, sanctions, trade policies or disputes or any “trade war” in the United States or in any country or region in the world in which the Company and its subsidiaries conduct business; |
(xi) | any changes in the price or trading volume of the Company Common Stock, in and of itself (it being understood that the underlying cause of such change may be taken into consideration when determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur to the extent not otherwise excluded under the Merger Agreement); |
(xii) | any failure by the Company and its subsidiaries to meet (A) any internal or public estimates or expectations of the Company’s revenue, earnings or other financial performance or results of operations for any period; or (B) any budgets, plans, projections or forecasts of its revenues, earnings or other financial performance or results of operations (it being understood that, in the case of each of the foregoing clauses (A) and (B), the underlying cause of any such failure may be taken into consideration when determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur to the extent not otherwise excluded under the Merger Agreement); |
(xiii) | the availability or cost of equity, debt or other financing to Parent or Merger Sub; |
TABLE OF CONTENTS
(xiv) | any transaction litigation or any demand or legal proceeding for appraisal of the fair value of any shares of Company Common Stock pursuant to the DGCL in connection with the Merger Agreement; |
(xv) | the identity of Parent, Merger Sub, or their respective affiliates as the acquiror of the Company; and |
(xvi) | any breach by Parent or Merger Sub of the Merger Agreement, |
• | amend or repeal the organizational documents of the Company or any of its subsidiaries or adopt any such new organizational documents or provision thereof (other than immaterial amendments to the organizational documents of any subsidiary of the Company); |
• | propose or adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, conversion, division, restructuring, recapitalization or other reorganization; |
• | issue, sell, deliver or agree or commit to issue, sell, deliver or authorize the issuance of any Company Securities (as defined in the Merger Agreement), except (i) in accordance with the terms of any award agreement under the Company Equity Plan (as defined in the Merger Agreement) or otherwise with respect to, and upon the vesting, exercise or settlement of, Company Options, Company RSAs, Company RSUs or Company PSUs, in each case, outstanding on the date of the Merger Agreement or granted after the date of the Merger Agreement in compliance with the Merger Agreement or (ii) for the issuance of SPAC Merger Earnout Shares in accordance with the Merger Agreement or the SPAC Merger Agreement; |
TABLE OF CONTENTS
• | except for transactions solely among the Company and its subsidiaries or solely among the subsidiaries of the Company, adjust, reclassify, split, combine, subdivide or redeem, repurchase, purchase or otherwise acquire or amend the terms of, directly or indirectly, any of its capital stock or other equity or voting interest of the Company, other than (i) the acquisitions of shares of Company Common Stock in connection with the surrender of shares of Company Common Stock by holders of Company Options to pay the exercise price of such Company Options, (ii) the withholding of shares of Company Common Stock to satisfy tax obligations incurred in connection with the exercise of Company Options or the vesting or settlement of Company RSAs, Company RSUs and Company PSUs, and (iii) the acquisition by the Company of Company Options, Company RSUs, Company PSUs and Company RSAs in connection with the forfeiture of such awards, in each case of clauses (i), (ii) and (iii), in accordance with their terms; |
• | (i) declare, set aside or pay any dividend or other distribution (whether in cash, shares or property or any combination thereof) in respect of any shares of capital stock or other equity or voting interest, except for dividends or other distributions made by any direct or indirect wholly owned subsidiary of the Company to the Company or one of its other wholly owned subsidiaries, (ii) modify the terms of any shares of its capital stock or other equity or voting interest or (iii) pledge or encumber any shares of its capital stock or other equity or voting interest; |
• | (A) incur, assume, endorse, guarantee, or otherwise become liable for any indebtedness, except (i) borrowings in the ordinary course of business under the Company’s credit facilities as in effect on the date of the Merger Agreement or under facilities that replace, renew, extend, refinance or refund such existing credit facilities (including indebtedness incurred to repay or refinance related fees and expenses); provided that any such new facilities (x) are on terms not materially less favorable to the Company and its subsidiaries, (y) are not in an aggregate principal amount or, in the case of any revolving facility, an aggregate committed amount, in excess of the outstanding aggregate principal amount or aggregate committed amount, as applicable, of the facilities being so replaced, renewed, extended, refinanced or refunded, plus defeasance costs, original issue discount, upfront fees and other similar and customary fees, commissions, costs and expenses incurred in connection with such replacement, renewal, extension, refinancing or refunding and (z) will be repaid in full at or prior to the Effective Time, (ii) guarantees or credit support provided by the Company or any of its subsidiaries of the obligations of the Company or any of its subsidiaries to the extent such indebtedness is in existence on the date of the Merger Agreement or incurred in compliance with this covenant, (iii) letters of credit, bank guarantees, performance bonds and surety bonds entered into in the ordinary course of business and (iv) any intercompany indebtedness between the Company and its wholly owned subsidiaries or among the Company’s wholly owned subsidiaries or (B) settle, waive, or forgive any indebtedness owed to the Company or any of its subsidiaries; |
• | (A) purchase any real property; (B) enter into any new lease agreement with respect to real property that is not leased by the Company or one of its subsidiaries as of the date of the Merger Agreement, other than any such lease providing for aggregate payments by the Company and its subsidiaries of less than $1,000,000 over the initial term thereof; or (C) with respect to any Lease (as defined in the Merger Agreement) for real property in effect on the date of the Merger Agreement, (1) waive, release, assign, or sublease any material rights or claims thereunder, (2) materially amend or modify the terms thereof, (3) except in the ordinary course of business, terminate such Lease for real property (other than as a result of expiration of the then-existing term), (4) except in the ordinary course of business, extend the term thereof, as in effect on the date of the Merger Agreement, or (5) grant any material waiver or give any consent thereunder; |
• | except as required by any Employee Plan (as defined in the Merger Agreement) set forth in the Company Disclosure Letter: (i) establish, enter into, adopt, materially amend or modify, or terminate any Employee Plan (or any plan, policy, agreement or arrangement that would constitute a material Employee Plan if in effect on the date of the Merger Agreement), other than in conjunction with annual renewals of group welfare benefits in the ordinary course of business; or (ii) increase, modify or amend (including to accelerate the time of payment, vesting or funding of, or provide for the payment of amounts not otherwise due with respect to) the salaries, wages, benefits, bonuses or other compensation or other benefits payable or provided to any current or former director, officer, employee or individual service provider, except in the ordinary course of business; (iii) enter into or grant any change in control, severance, transaction, retention or similar agreement with any current or former employees, officers, directors or individual service providers of the Company or |
TABLE OF CONTENTS
• | commence, settle, release, waive or compromise any pending or threatened legal proceeding (x) that involves any admission of liability or any injunctive or equitable relief or (y) for an amount in excess of $1,000,000 individually or $5,000,000 in the aggregate, other than any settlement of any legal proceeding or investigation (i) where the amount paid or to be paid by the Company or any of its subsidiaries is covered by insurance coverage maintained by the Company or any of its subsidiaries, (ii) for an amount not in excess of the amount, if any, reflected or reserved in the balance sheet (or the notes thereto) of the Company, (iii) in compliance with the terms of the Merger Agreement or (iv) involving any dispute between one or more of Parent or Merger Sub, on the one hand, and the Company, on the other hand, relating to the Merger Agreement or the transactions contemplated in the Merger Agreement; |
• | materially change the Company’s or its subsidiaries’ methods, principles or practices of financial accounting or annual accounting period, except as required by GAAP, Regulation S-X promulgated under the Securities Act of 1933 (or any interpretation thereof), or by any governmental authority; |
• | incur or commit to incur any capital expenditures other than (i) as set forth in the Company Disclosure Letter (the “Capex Budget”), or (ii) capital expenditures that do not exceed the Capex Budget by more than $15,000,000 in the aggregate; |
• | enter into, modify in any material respect, amend in any material respect (including granting any material refunds, credits, rebates, allowances to customers thereunder) or terminate (other than any material contract that has expired in accordance with its terms) any material contract except, in each case, in the ordinary course of business; provided that material contracts relating to acquisitions and dispositions, indebtedness and leases will be exclusively governed by the corresponding restrictions described in this section; |
• | (i) make (except in a manner consistent with past practice), change or revoke any material tax election, (ii) make any material change to any method of tax accounting, (iii) amend any material tax return, (iv) settle or compromise any material tax action, claim or assessment, (v) consent to any extension or waiver of the limitation period applicable to any claim or assessment in respect of material taxes, (vi) enter into any closing agreement with respect to a material amount of taxes, (vii) surrender any right to claim a material refund of taxes or (viii) initiate or enter into any voluntary disclosure agreement with a governmental authority with respect to a material amount of taxes; |
• | acquire any division, assets, properties, businesses or equity securities or otherwise make any investment in any person (including by merger, consolidation or acquisition of stock or assets) for consideration in excess of $10,000,000 in the aggregate, other than (i) in or from any wholly owned subsidiary of the Company, or (ii) assets in the ordinary course of business; |
• | sell, license, pledge, abandon, assign, transfer, or otherwise dispose of, any of the Company’s or its subsidiaries’ material assets (other than intellectual property, which is the subject of the following bullet), other than such sales, assignments, transfers or other dispositions that (i) are in the ordinary course of business or (ii) do not have a purchase price that exceeds $10,000,000 in the aggregate; |
• | sell, assign, transfer, license, abandon, cancel, permit to lapse, pledge, encumber or otherwise dispose of any material Company Intellectual Property (as defined in the Merger Agreement), other than (i) the grant of non-exclusive licenses in the ordinary course of business and in a manner not inconsistent with past practices, (ii) the expiration of Registered Intellectual Property (as defined in the Merger Agreement) at the end of their statutory term, or (iii) pledges or encumbrances under the Existing Credit Agreement as in effect on the date of the Merger Agreement or any Permitted Lien (as defined in the Merger Agreement); |
• | engage in any transaction with, or enter into any agreement, arrangement or understanding with, any affiliate of the Company or other person covered by Item 404 of Regulation S-K promulgated by the SEC that would be required to be disclosed pursuant to Item 404; |
• | effectuate or announce any plant closing, mass employee layoff, furlough or any other action that would trigger the notice requirements of WARN (as defined in the Merger Agreement); |
• | enter into, amend, or terminate any collective bargaining agreement; |
TABLE OF CONTENTS
• | make any loans, advances or capital contributions to, any other person, except for (i) extensions of credit to customers in the ordinary course of business, (ii) advances to directors, officers and other employees for travel and other business-related expenses, in each case, in the ordinary course of business and in compliance in all material respects with the Company’s or its subsidiaries’ policies related thereto, and (iii) loans, advances or capital contributions to, any direct or indirect wholly owned subsidiaries of the Company; or |
• | agree, resolve or commit to take any of the actions prohibited by the Merger Agreement. |
TABLE OF CONTENTS
TABLE OF CONTENTS
• | “Acceptable Confidentiality Agreement” means any confidentiality agreement (x) in effect as of the date of the Merger Agreement or (y) executed, delivered and effective after the date of the Merger Agreement and containing terms that are not less favorable in any material respect to the Company than those contained in the Confidentiality Agreement (as defined in the Merger Agreement), except that such confidentiality agreement need not contain any “standstill” or similar provision or otherwise prohibit the making of any Acquisition Proposal. |
• | “Acquisition Proposal” means any offer or proposal (other than an offer or proposal by Parent or Merger Sub) to engage in an Acquisition Transaction. |
• | “Acquisition Transaction” means any transaction or series of related transactions (other than the Merger) involving: (i) any direct or indirect purchase or other acquisition by any person or group, or equityholders of any such person or group, whether from the Company or any other person(s), of shares of Company Common Stock representing more than 20% of the Company Common Stock outstanding after giving effect to the consummation of such purchase or other acquisition, including pursuant to a tender offer or exchange offer by any person or group that, if consummated in accordance with its terms, would result in such person or group beneficially owning more than 20% of the Company Common Stock outstanding after giving effect to the consummation of such tender or exchange offer; (ii) any direct or indirect purchase or other acquisition by any person or group of more than 20% of the consolidated assets, net revenue or net income of the Company and its subsidiaries taken as a whole (measured by the fair market value thereof as determined in good faith by the |
TABLE OF CONTENTS
• | “Superior Proposal” means any unsolicited and bona fide written Acquisition Proposal for an Acquisition Transaction that did not result from a material breach of the non-solicitation terms of the Merger Agreement and that is on terms that the Company Board (or a committee thereof) has determined in good faith (after consultation with its financial advisors and outside legal counsel) would be more favorable to the Company stockholders from a financial point of view than the Merger (taking into account (i) any changes to the terms of the Merger Agreement offered by Parent in writing in response to such Superior Proposal in accordance with the Merger Agreement and (ii) all legal, regulatory, financial, timing and financing aspects of such proposal (including certainty of closing), the identity of the person making the proposal, and other aspects of such proposal that the Company Board (or a committee thereof) considers in good faith to be relevant) and (iii) is reasonably likely to be completed on the terms proposed (taking into account all legal, regulatory, financial, timing and financing aspects of such proposal (including certainty of closing), the identity of the person making the proposal and other aspects of such proposal that the Company Board (or a committee thereof) considers in good faith to be relevant). For purposes of the reference to an “Acquisition Proposal” in this definition, all references to “20%” in the definition of “Acquisition Transaction” will be deemed to be references to “50%.” |
• | solicit, initiate, propose or knowingly induce the making, submission or announcement of, or knowingly encourage, facilitate or assist, any inquiry, proposal or offer with respect to, that constitutes or could reasonably be expected to lead to, an Acquisition Proposal; |
• | furnish or otherwise provide to any person (other than Parent, Merger Sub or any designees of Parent or Merger Sub) any non-public information relating to the Company or any of its subsidiaries or afford to any person access to the business, properties, assets, books, records or personnel, of the Company or any of its subsidiaries, in any such case with the intent to knowingly induce the making, submission or announcement of, or to knowingly encourage or knowingly facilitate, any proposal or offer with respect to, that constitutes or would reasonably be expected to lead to an Acquisition Proposal; |
• | participate or otherwise engage in, enter into, continue or otherwise participate in, discussions or negotiations with any person (or its representatives, including potential financing sources of such person) with respect to an Acquisition Proposal (or inquiry, proposal, offer or any other effort or attempt that could reasonably be expected to lead to an Acquisition Proposal), in each case, other than informing such persons of the existence of the non-solicitation terms of the Merger Agreement or contacting such person solely in order to clarify (but not to negotiate) the terms and conditions of any Acquisition Proposal; |
• | otherwise cooperate with or knowingly assist or participate in or knowingly facilitate the making of any Acquisition Proposal, including granting a waiver, amendment or release under any pre-existing standstill or similar provision to the extent necessary to allow for an Acquisition Proposal, or amendment to an Acquisition Proposal to be made to the Company or the Company Board; |
• | approve, endorse or recommend an Acquisition Proposal; or |
• | approve, endorse, recommend or enter into, or propose to approve, recommend or enter into, any letter of intent, memorandum of understanding, merger agreement, acquisition agreement or other contract relating to an Acquisition Transaction (including any “clean team” or similar arrangement), other than an Acceptable Confidentiality Agreement (any such letter of intent, memorandum of understanding, merger agreement, acquisition agreement or other contract relating to an Acquisition Transaction, an “Alternative Acquisition Agreement”). |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | provide Parent with prompt notice of all transaction litigation against the Company and its subsidiaries and its and their directors and executive officers (including by providing copies of all pleadings with respect thereto) and keep Parent reasonably informed with respect to the status thereof; give Parent the opportunity to participate in (but not control) the defense, settlement or prosecution of such transaction litigation, including by giving Parent the opportunity to review and comment on all filings and responses to be made by the Company in connection with any transaction litigation; and consult with Parent with respect to the defense, settlement and prosecution of such transaction litigation. The Company may not compromise or settle or enter into any agreement, or consent to the entry of, any order or judgment with respect to such transaction litigation unless Parent has consented thereto in writing (which consent will not be unreasonably withheld, conditioned or delayed); |
• | cooperate with Parent and use its reasonable best efforts to take, or cause to be taken, all actions, and do or cause to be done all things reasonably necessary, proper or advisable on its part pursuant to applicable laws and the rules and regulations of Nasdaq to cause the delisting by the Company of the Company Common Stock from Nasdaq as promptly as practicable after the Effective Time and the deregistration of the Company Common Stock pursuant to the Exchange Act as promptly as practicable after such delisting; |
• | be permitted to take all such actions as may be reasonably necessary or advisable to cause the Merger, and any dispositions of equity securities of the Company (including derivative securities) (including the disposition, cancellation, or deemed disposition and cancellation of Company Common Stock, SPAC Merger Earnout Shares, Sponsor Earnout Shares, Company Options, Company RSUs, Company PSUs or Company RSAs) in connection with the Merger by each individual who is a director or executive officer of the Company, to be exempt under Rule 16b-3 promulgated under the Exchange Act; |
• | as promptly as reasonably practicable following the date of the Merger Agreement (but in any event within 25 business days), the Company (with the assistance and cooperation of Parent and Merger Sub as reasonably requested by the Company) will prepare and file with the SEC a preliminary proxy statement relating to the Special Meeting. Subject to the terms of the Merger Agreement, the Company will include the Company Board Recommendation (as defined in the Merger Agreement) in the proxy statement. Subject to applicable law, the Company will use its reasonable best efforts to cause the proxy statement to be disseminated to the Company stockholders as promptly as reasonably practicable, and in no event more than five business days, following the filing thereof with the SEC and confirmation from the SEC that it will not review, or that it has completed its review of, the proxy statement, which confirmation will be deemed to have occurred if the SEC has not affirmatively notified the Company by 11:59 p.m., New York City time, on the tenth calendar day following such filing with the SEC that the SEC will or will not be reviewing the proxy statement; and |
• | at or prior to the Closing, the Company will cause the termination, effective as of the Closing, of each affiliate agreement, other than certain affiliate contracts or other contracts set forth in the Company Disclosure Letter, in its entirety without any further liability or obligation of the Company or any of its subsidiaries from and after the Closing. |
• | the Company’s receipt of the Requisite Stockholder Approval at the Special Meeting; |
TABLE OF CONTENTS
• | the waiting periods (and any extensions thereof, including any agreement with any governmental authority to delay the Closing entered into in connection therewith) applicable to the Transactions pursuant to the HSR Act will have expired or otherwise been terminated; and |
• | no law, injunction or order (whether temporary, preliminary or permanent) by any governmental authority of competent jurisdiction prohibiting, enjoining or otherwise making illegal the consummation of the Merger will have been enacted, entered or promulgated and be continuing in effect. |
• | the representations and warranties of the Company relating to organization and good standing, corporate power and enforceability, Company Board approval, certain aspects of the Company’s capitalization and brokers will be true and correct (disregarding all qualifications or limitations as to “materiality,” “Company Material Adverse Effect” or words of similar import) in all material respects on the Closing Date as if made on the Closing Date (except to the extent that any such representation and warranty expressly speaks as of a specific date, in which case such representation and warranty will be true and correct in all material respects only as of such specified date); |
• | the representations and warranties of the Company relating to certain other aspects of the Company’s capitalization will be true and correct (disregarding all qualifications or limitations as to “materiality,” “Company Material Adverse Effect” or words of similar import) in all respects on the Closing Date as if made on the Closing Date (except to the extent that any such representation and warranty expressly speaks as of a specific date, in which case such representation and warranty will be true and correct in all respects only as of such specified date), except for de minimis inaccuracies; |
• | the representations and warranties of the Company relating to the absence of certain changes will be true and correct (disregarding all qualifications or limitations as to “materiality,” “Company Material Adverse Effect” or words of similar import) in all respects on the Closing Date as if made on the Closing Date; |
• | the other representations and warranties of the Company will be true and correct (disregarding all qualifications or limitations as to “materiality,” “Company Material Adverse Effect” or words of similar import) on the date of the Merger Agreement and on the Closing Date as if made on the Closing Date (except to the extent that any such representation and warranty expressly speaks as of a specific date, in which case such representation and warranty will be true and correct only as of such specified date), except where the failure of such representations and warranties to be so true and correct would not, individually or in the aggregate, have a Company Material Adverse Effect; |
• | the Company will have complied in all material respects with the covenants and obligations of the Merger Agreement required to be performed and complied with by it at or prior to the Closing; |
• | since the date of the Merger Agreement, there will not have occurred a Company Material Adverse Effect; |
• | Parent and Merger Sub will have received a certificate of the Company, validly executed for and on behalf of the Company and in its name by a duly authorized executive officer thereof, certifying that the conditions set forth in the immediately preceding six bullets have been satisfied; and |
• | at or prior to the Closing, the Company will have delivered to Parent, in a form reasonably satisfactory to Parent, a certificate complying with Treasury Regulation Section 1.1445-2(c)(3), certifying that the Company is not, and has not been during the applicable period described in Section 897(c)(1)(A)(ii) of the Code, a “United States real property holding corporation” within the meaning of Section 897(c) of the Code, together with a copy of the notice to the IRS provided in accordance with Treasury Regulation Section 1.897-2(h)(2). |
• | the representations and warranties of Parent and Merger Sub set forth in the Merger Agreement will be true and correct (disregarding all qualifications or limitations as to “materiality,” “Parent Material Adverse Effect” or words of similar import) as of the Closing Date as if made on and as of such date (except to the |
TABLE OF CONTENTS
• | Parent and Merger Sub will have complied in all material respects with the covenants and obligations of the Merger Agreement required to be performed and complied with by Parent and Merger Sub at or prior to the Closing; and |
• | the Company will have received a certificate of Parent and Merger Sub, validly executed for and on behalf of Parent and Merger Sub and in their respective names by a duly authorized officer thereof, certifying that the conditions set forth in the immediately preceding two bullets have been satisfied. |
• | At any time prior to the Effective Time (whether prior to or after the receipt of the Requisite Stockholder Approval), by mutual written agreement of Parent and the Company. |
• | By either Parent or the Company, at any time prior to the Effective Time (whether prior to or after the receipt of the Requisite Stockholder Approval), if (i) any permanent injunction or other final and non-appealable judgment or order issued by any court or other governmental authority of competent jurisdiction preventing the consummation of the Merger is in effect that, in each case, prohibits, makes illegal or enjoins the consummation of the Merger and has become final and non-appealable or (ii) any statute, rule or regulation has been enacted, entered or enforced that prohibits, makes illegal or enjoins the consummation of the Merger (a “Legal Restraint”); provided that this right to terminate will not be available to a party if the issuance of such Legal Restraint was primarily due to the failure of such party (treating Parent and Merger Sub as one party for this purpose) to perform any of its obligations under the Merger Agreement or if such party (treating Parent and Merger Sub as one party for this purpose) has failed to comply with its antitrust and regulatory obligations under the Merger Agreement. |
• | By either Parent or the Company, at any time prior to the Effective Time (whether prior to or after the receipt of the Requisite Stockholder Approval), if the Effective Time has not occurred by the Termination Date; provided that this right to terminate will not be available to a party (treating Parent and Merger Sub as one party for this purpose) if the failure of the Merger to be consummated prior to the Termination Date was primarily due to the failure of such party to perform any of its obligations under the Merger Agreement (it being understood that Parent’s failure to consummate the Closing due to the unavailability of the Debt Financing will not in itself be deemed to be an action or failure to act solely for purposes of this termination right). |
• | By either Parent or the Company, at any time prior to the Effective Time, if the Company fails to obtain the Requisite Stockholder Approval at the Special Meeting (or any adjournment or postponement thereof) at which a vote is taken on the Merger. |
• | By Parent, if the Company has breached or failed to perform any of its representations, warranties, covenants or other agreements contained in the Merger Agreement, which breach or failure to perform would result in a failure of a condition relating to the accuracy of the Company’s representations and warranties or the performance of the Company’s covenants, except that if such breach is capable of being cured prior to the Termination Date, Parent will not be entitled to terminate the Merger Agreement prior to the delivery by Parent to the Company of written notice of such breach, delivered at least forty-five days prior to such termination, stating Parent’s intention to terminate the Merger Agreement and the basis for such termination, it being understood that Parent will not be entitled to terminate the Merger Agreement if such breach has been cured prior to termination; provided that Parent will not have the right to terminate the Merger Agreement if it or Merger Sub is then in material breach of any representations, warranties, covenants or other agreements contained in the Merger Agreement that would result in a failure of a condition relating to the accuracy of Parent’s and Merger Sub’s representations and warranties or the performance of their covenants. |
TABLE OF CONTENTS
• | By Parent, if at any time prior to the Company’s receipt of the Requisite Stockholder Approval, the Company Board has effected a Company Board Recommendation Change. |
• | By the Company, if Parent or Merger Sub has breached or failed to perform any of its respective representations, warranties, covenants or other agreements contained in the Merger Agreement, which breach or failure to perform would result in a failure of a condition relating to the accuracy of Parent’s and Merger Sub’s representations and warranties or the performance of their covenants, except that if such breach is capable of being cured prior to the Termination Date, the Company will not be entitled to terminate the Merger Agreement prior to the delivery by the Company to Parent of written notice of such breach, delivered at least forty-five days prior to such termination, stating the Company’s intention to terminate the Merger Agreement and the basis for such termination, it being understood that the Company will not be entitled to terminate the Merger Agreement if such breach has been cured prior to termination; provided that the Company will not have the right to terminate the Merger Agreement if it is then in material breach of any representations, warranties, covenants or other agreements contained in the Merger Agreement that would result in a failure of a condition relating to the accuracy of the Company’s representations and warranties or the performance of the Company’s covenants. |
• | By the Company, at any time prior to receiving the Requisite Stockholder Approval, in order to substantially concurrently enter into an Alternative Acquisition Agreement providing for a Superior Proposal received after the date of the Merger Agreement, if the Company (A) has complied in all material respects with the non-solicitation terms of the Merger Agreement in connection with such Superior Proposal and (B) pays to Parent in immediately available funds the Company Termination Fee substantially concurrently with such termination. |
• | By the Company, if (i) all of the mutual conditions and the conditions to the obligations of Parent and Merger Sub to consummate the Merger are satisfied or waived (other than those conditions that by their terms are to be satisfied at the Closing, so long as such conditions are at the time of termination capable of being satisfied), (ii) the Company has irrevocably confirmed to Parent in writing that it is prepared to consummate the Closing and (iii) Parent fails to consummate the Transactions by the date that is three business days after the later of (x) the first date on which Parent is required to consummate the Closing pursuant to the Merger Agreement and (y) the date of such notice. |
• | Tail-Fee Scenario. If (A) the Merger Agreement is validly terminated pursuant to (x) the Termination Date termination right (provided that at the Termination Date, all of the mutual conditions (other than the receipt of the Requisite Stockholder Approval) and all of the conditions to the Company’s obligations have been satisfied or waived (other than those conditions that by their terms are to be satisfied at the Closing, so long as such conditions are at the time of termination capable of being satisfied as if such time were the Closing)), (y) the failure to obtain the Requisite Stockholder Approval termination right or (z) the Company Breach termination right; (B) following the execution and delivery of the Merger Agreement and prior to such termination, any person has publicly announced or provided to the Company Board or management of the Company an Acquisition Proposal and not publicly (in the case of an Acquisition Proposal that has been |
TABLE OF CONTENTS
• | Company Board Recommendation Change. If the Merger Agreement is validly terminated pursuant to the Company Board Recommendation Change termination right, then the Company must promptly (and in any event within three business days) following such termination pay, or cause to be paid, to Parent the Company Termination Fee by wire transfer of immediately available funds to an account or accounts designated in writing by Parent; and |
• | Superior Proposal. If the Merger Agreement is validly terminated pursuant to the Superior Proposal termination right, then the Company must substantially concurrently with such termination pay, or cause to be paid, to Parent the Company Termination Fee by wire transfer of immediately available funds to an account or accounts designated in writing by Parent. |
TABLE OF CONTENTS
• | the Company Board (or a committee thereof) may effect a Company Board Recommendation Change in response to an Intervening Event (as defined below) if the Company Board (or a committee thereof) determines in good faith (after consultation with its financial advisors and outside legal counsel) that the failure to do so would be reasonably likely to be inconsistent with its fiduciary duties under applicable law; provided that the Company Board (or a committee thereof) will not effect such a Company Board Recommendation Change unless (1) the Company has provided prior written notice to Parent at least four business days in advance (the “Intervening Event Notice Period”) to the effect that the Company Board (or a committee thereof) intends to effect a Company Board Recommendation Change, which notice will specify the basis for such Company Board Recommendation Change; (2) prior to effecting such Company Board Recommendation Change, the Company and its representatives, during the Intervening Event Notice Period, negotiate with Parent and its representatives in good faith (to the extent that Parent desires to so negotiate) to enable Parent to make such adjustments to the terms and conditions of the Merger Agreement and the Financing Letters in such a manner that would obviate the need to effect a Company Board Recommendation Change (and, in the event the Intervening Event thereafter changes in any material respect, the Company will be required to deliver a new written notice to Parent and to comply with such requirements with respect to such new written notice, with the Intervening Event Notice Period in respect of such new written notice being three business days); and (3) at the end of the Intervening Event Notice Period and prior to taking any such action, the Company Board has considered in good faith any such proposals for amendments committed to by Parent in writing to make revisions to the terms of the Merger Agreement and the Financing Letters, and has determined in good faith (after consultation with its financial advisors and outside legal counsel) that the failure to effect a Company Board Recommendation Change would continue to be reasonably likely to be inconsistent with the Company Board’s fiduciary duties under applicable law if such changes proposed by Parent were to be given effect; or |
• | if the Company has received an unsolicited and bona fide Acquisition Proposal that did not result from a material breach of the non-solicitation terms of the Merger Agreement and that the Company Board has determined in good faith (after consultation with its financial advisors and outside legal counsel) constitutes a Superior Proposal, then the Company Board may (A) effect a Company Board Recommendation Change with respect to such Acquisition Proposal or (B) cause the Company to terminate the Merger Agreement in order to substantially concurrently enter into an Alternative Acquisition Agreement with respect to such Acquisition Proposal; provided that the Company Board (or a committee thereof) will not take any action described in the foregoing clauses (A) and (B) unless (1) the Company Board determines in good faith (after consultation with its financial advisors and outside legal counsel) that the failure to do so would be reasonably likely to be inconsistent with its fiduciary duties under applicable law; (2) (i) the Company has provided prior written notice to Parent at least four business days in advance (such notice period, including any extension thereto, the “Acquisition Proposal Notice Period”) to the effect that the Company Board (or a committee thereof) intends to take the actions described in clauses (A) or (B) above, including the identity of the person |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | each person or group known to us who beneficially owns more than 5% of shares of the Company Common Stock; |
• | each of our directors; |
• | each of our named executive officers; and |
• | all of our directors and executive officers as a group. |
Name and Address of Beneficial Owner1 | Number of Shares of Company Common Stock | Percent of Company Common Stock | ||||
Githesh Ramamurthy2 | 36,568,913 | 6.05% | ||||
Tim Welsh3 | 362,641 | * | ||||
Brian Herb4 | 413,175 | * | ||||
Mary Jo Prigge5 | 769,085 | * | ||||
John Goodson | — | * | ||||
Neil de Crescenzo6 | 241,839 | * | ||||
Barak Eilam7 | 22,013 | * | ||||
William Ingram8 | 279,137 | * | ||||
Eileen Schloss9 | 98,412 | * | ||||
John Schweitzer10 | 11,625 | * | ||||
Teri Williams11 | 206,243 | * | ||||
Eric Wei | — | * | ||||
All directors and executive officers as a group (11 individuals)12 | 38,096,815 | 6.30% | ||||
Five Percent Holders: | ||||||
T. Rowe Price Associates, Inc.13 | 43,837,469 | 7.41% | ||||
Vanguard Portfolio Management14 | 35,747,819 | 6.05% | ||||
Akre Capital Management, LLC15 | 30,313,000 | 5.13% | ||||
* | Means less than 1%. |
(1) | Unless otherwise noted, the business address of each of the directors and officers is 167 N. Green Street, 9th Floor, Chicago, Illinois 60607. The table excludes (i) the contingent right of Mr. Ramamurthy, Mr. Herb, Ms. Prigge, Ms. Schloss, Ms. Williams and Mr. Ingram to receive, subject to adjustment, 1,298,389, 9,064, 22,707, 7,698, 7,698 and 7,698 shares, respectively, based on the Company achieving certain trading price targets for its common stock or undergoing a change of control and (ii) shares of common stock underlying Company PSUs, which represent a contingent right to receive a number of shares of common stock, cash or a combination thereof based on total shareholder return realized by stockholders over a specified period. |
(2) | Includes (i) 23,896,593 shares of the Company Common Stock and (ii) 12,672,320 shares of the Company Common Stock underlying stock options that are currently vested and exercisable. As a result of Mr. Ramamurthy’s commitment to exercise such options solely through ‘cashless’ means, he does not have a right to acquire the gross number of shares underlying such stock options pursuant to Rule 13d-3(d)(1) within 60 days of November 17, 2026. |
TABLE OF CONTENTS
(3) | Includes 362,641 shares of the Company Common Stock. |
(4) | Includes 413,175 shares of the Company Common Stock. |
(5) | Includes 769,085 shares of the Company Common Stock. |
(6) | Includes 241,839 shares of the Company Common Stock. |
(7) | Includes 22,013 shares of the Company Common Stock. |
(8) | Includes (i) 108,862 shares of the Company Common Stock and (ii) 170,275 shares of the Company Common Stock underlying stock options that are currently vested and exercisable. |
(9) | Includes (i) 81,384 shares of the Company Common Stock and (ii) 17,028 shares of the Company Common Stock underlying stock options that are currently vested and exercisable. |
(10) | Includes 11,625 shares of the Company Common Stock. |
(11) | Includes (i) 35,968 shares of the Company Common Stock and (ii) 170,275 shares of the Company Common Stock underlying stock options that are currently vested and exercisable. |
(12) | Includes (i) 24,998,707 shares of the Company Common Stock and (ii) 13,098,558 shares of the Company Common Stock underlying stock options that are currently vested and exercisable. |
(13) | Based on Schedule 13G filed by T. Rowe Price Associates, Inc. with the SEC on August 14, 2026. |
(14) | Based on Schedule 13G filed by Vanguard Portfolio Management with the SEC on April 29, 2026. |
(15) | Based on Schedule 13G filed by Akre Capital Management, LLC with the SEC on May 15, 2026. |
TABLE OF CONTENTS
TABLE OF CONTENTS
• | you must deliver to the Company a written demand for appraisal before the vote on the Merger Agreement at the Special Meeting. This written demand for appraisal must be in addition to and separate from any proxy or vote abstaining from, voting against or otherwise failing to vote for the Merger Proposal. Voting against or failing to vote for the Merger Proposal by itself does not constitute a demand for appraisal within the meaning of Section 262 of the DGCL. The demand must reasonably inform us of the identity of the holder of record holding the shares for which appraisal is demanded, the intention of the person to demand appraisal of his, her or its shares and, in case of a demand made by a beneficial owner, must be accompanied by documentary evidence of such beneficial owner’s beneficial ownership of the shares and a statement that such documentary evidence is a true and correct copy of what it purports to be and must provide an address at which such beneficial owner consents to receive notices given by the surviving corporation under Section 262 of the DGCL and to be set forth on the verified list required by Section 262(f) of the DGCL. A stockholder’s and beneficial owner’s failure to make a written demand for appraisal before the vote with respect to the Merger Proposal is taken will constitute a waiver of appraisal rights; |
• | you must not vote in favor of, or consent in writing to, the Merger Proposal with respect to such shares. A vote in favor of the Merger Proposal, whether by proxy submitted by mail, over the Internet or by telephone or at the Special Meeting, will constitute a waiver of your appraisal rights in respect of the shares so voted and will nullify any previously filed written demands for appraisal. A proxy which does not contain voting instructions will, unless revoked, be voted in favor of the Merger Proposal. Therefore, a stockholder who submits a proxy and who wishes to exercise appraisal rights must effectively revoke that proxy pursuant to one of the means described in this proxy statement; |
• | you must continuously hold (in the case of a stockholder demanding appraisal) or beneficially own (in the case of a beneficial owner demanding appraisal) your shares of Company Common Stock from the date of making the demand through the Effective Time. You will lose your appraisal rights if you are a holder of record and transfer the shares, or if you are a beneficial owner and cease to beneficially own such shares, before the Effective Time; |
• | you or the surviving corporation must file a petition in the Delaware Court of Chancery requesting a determination of the fair value of the shares within 120 days after the Effective Time. The surviving corporation is under no obligation to file any petition and has no present intention of doing so; and |
• | you must otherwise comply with the applicable procedures and requirements set forth in Section 262 of the DGCL. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 24, 2026, including the portions of the Company’s definitive proxy statement on Schedule 14A for its 2026 annual meeting of stockholders, filed with the SEC on April 7, 2026, that are incorporated by reference into Part III thereof; |
• | the Company’s Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2026, June 30, 2026, and September 30, 2026 filed with the SEC on April 30, 2026, July 30, 2026 and October 29, 2026, respectively; and |
• | the Company’s Current Reports on Form 8-K or 8-K/A, filed with the SEC on March 2, 2026, April 30, 2026 (with respect to Item 5.02 only), May 22, 2026, May 29, 2026 and October 15, 2026. |
TABLE OF CONTENTS
TABLE OF CONTENTS
Page | |||||||||
ARTICLE I DEFINITIONS & INTERPRETATIONS | A-2 | ||||||||
1.1 | Certain Definitions | A-2 | |||||||
1.2 | Index of Defined Terms | A-15 | |||||||
1.3 | Certain Interpretations | A-16 | |||||||
ARTICLE II THE MERGER | A-18 | ||||||||
2.1 | The Merger | A-18 | |||||||
2.2 | The Effective Time | A-18 | |||||||
2.3 | The Closing | A-18 | |||||||
2.4 | Effect of the Merger | A-18 | |||||||
2.5 | Certificate of Incorporation and Bylaws | A-18 | |||||||
2.6 | Directors and Officers | A-18 | |||||||
2.7 | Effect on Capital Stock | A-19 | |||||||
2.8 | Treatment of Equity Awards | A-20 | |||||||
2.9 | Effect on Other Company Securities; Company Earnout Shares | A-22 | |||||||
2.10 | Exchange of Certificates | A-22 | |||||||
2.11 | No Further Ownership Rights in Company Common Stock | A-24 | |||||||
2.12 | Lost, Stolen or Destroyed Certificates | A-24 | |||||||
2.13 | Required Withholding | A-24 | |||||||
ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE COMPANY | A-24 | ||||||||
3.1 | Organization; Good Standing | A-25 | |||||||
3.2 | Corporate Power; Enforceability | A-25 | |||||||
3.3 | Company Board Approval; Fairness Opinion; Anti-Takeover Laws | A-25 | |||||||
3.4 | Requisite Stockholder Approval | A-26 | |||||||
3.5 | Non-Contravention | A-26 | |||||||
3.6 | Requisite Governmental Approvals | A-26 | |||||||
3.7 | Company Capitalization | A-26 | |||||||
3.8 | Subsidiaries | A-27 | |||||||
3.9 | Company SEC Documents | A-28 | |||||||
3.10 | Company Financial Statements; Internal Controls; Indebtedness | A-28 | |||||||
3.11 | No Undisclosed Liabilities | A-29 | |||||||
3.12 | Absence of Certain Changes | A-29 | |||||||
3.13 | Material Contracts | A-29 | |||||||
3.14 | Real Property | A-30 | |||||||
3.15 | Environmental Matters | A-30 | |||||||
3.16 | Intellectual Property | A-30 | |||||||
3.17 | Tax Matters | A-31 | |||||||
3.18 | Employee Benefits | A-32 | |||||||
3.19 | Labor Matters | A-34 | |||||||
3.20 | Compliance with Laws | A-34 | |||||||
3.21 | Data Privacy; IT Systems | A-35 | |||||||
3.22 | Legal Proceedings; Orders | A-35 | |||||||
3.23 | Insurance | A-35 | |||||||
3.24 | Anti-Corruption; Anti-Money Laundering; Sanctions Compliance | A-35 | |||||||
3.25 | Brokers | A-36 | |||||||
TABLE OF CONTENTS
Page | |||||||||
3.26 | Company Information | A-36 | |||||||
3.27 | Related Party Transactions | A-36 | |||||||
3.28 | Government Contracts | A-36 | |||||||
3.29 | Customer Contracts | A-36 | |||||||
3.30 | Vendor Contracts | A-36 | |||||||
3.31 | No Other Representations or Warranties | A-37 | |||||||
ARTICLE IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB | A-37 | ||||||||
4.1 | Organization; Good Standing | A-37 | |||||||
4.2 | Corporate Power; Enforceability | A-37 | |||||||
4.3 | Non-Contravention | A-37 | |||||||
4.4 | Requisite Governmental Approvals | A-38 | |||||||
4.5 | [Reserved] | A-38 | |||||||
4.6 | Legal Proceedings; Orders | A-38 | |||||||
4.7 | Ownership of Company Common Stock | A-38 | |||||||
4.8 | Brokers | A-38 | |||||||
4.9 | Operations of Parent and Merger Sub | A-38 | |||||||
4.10 | No Parent Vote or Approval Required | A-38 | |||||||
4.11 | Guarantee | A-38 | |||||||
4.12 | Financing | A-38 | |||||||
4.13 | Stockholder and Management Arrangements | A-40 | |||||||
4.14 | Solvency | A-40 | |||||||
4.15 | Non-Reliance on Company Estimates, Projections, Forecasts, Forward-Looking Statements and Business Plans | A-40 | |||||||
4.16 | Parent and Merger Sub Information | A-41 | |||||||
4.17 | No Other Representations or Warranties | A-41 | |||||||
ARTICLE V INTERIM OPERATIONS OF THE COMPANY | A-41 | ||||||||
5.1 | Affirmative Obligations | A-41 | |||||||
5.2 | Forbearance Covenants | A-41 | |||||||
5.3 | No Solicitation | A-44 | |||||||
5.4 | No Control of the Other Party’s Business | A-48 | |||||||
ARTICLE VI ADDITIONAL COVENANTS | A-48 | ||||||||
6.1 | Required Action and Forbearance; Efforts | A-48 | |||||||
6.2 | Antitrust and Regulatory Matters | A-48 | |||||||
6.3 | Proxy Statement | A-50 | |||||||
6.4 | Company Stockholder Meeting | A-51 | |||||||
6.5 | Financing | A-52 | |||||||
6.6 | Financing Cooperation | A-56 | |||||||
6.7 | Anti-Takeover Laws | A-59 | |||||||
6.8 | Access | A-60 | |||||||
6.9 | Section 16(b) Exemption | A-60 | |||||||
6.10 | Directors’ and Officers’ Exculpation, Indemnification and Insurance | A-60 | |||||||
6.11 | Employee Matters | A-62 | |||||||
6.12 | Obligations of Merger Sub | A-64 | |||||||
6.13 | Notification of Certain Matters | A-64 | |||||||
TABLE OF CONTENTS
Page | |||||||||
6.14 | Public Statements and Disclosure | A-64 | |||||||
6.15 | Transaction Litigation | A-64 | |||||||
6.16 | Stock Exchange Delisting; Deregistration | A-64 | |||||||
6.17 | Additional Agreements | A-65 | |||||||
6.18 | Parent Vote | A-65 | |||||||
6.19 | Certain Arrangements | A-65 | |||||||
6.20 | Termination of Agreements | A-65 | |||||||
ARTICLE VII CONDITIONS TO THE MERGER | A-65 | ||||||||
7.1 | Conditions to Each Party’s Obligations to Effect the Merger | A-65 | |||||||
7.2 | Conditions to the Obligations of Parent and Merger Sub | A-65 | |||||||
7.3 | Conditions to the Company’s Obligations to Effect the Merger | A-66 | |||||||
ARTICLE VIII TERMINATION, AMENDMENT AND WAIVER | A-66 | ||||||||
8.1 | Termination | A-66 | |||||||
8.2 | Manner and Notice of Termination; Effect of Termination | A-68 | |||||||
8.3 | Fees and Expenses | A-68 | |||||||
8.4 | Amendment | A-71 | |||||||
8.5 | Extension; Waiver | A-71 | |||||||
ARTICLE IX GENERAL PROVISIONS | A-71 | ||||||||
9.1 | Survival of Representations, Warranties and Covenants | A-71 | |||||||
9.2 | Notices | A-71 | |||||||
9.3 | Assignment | A-72 | |||||||
9.4 | Confidentiality | A-73 | |||||||
9.5 | Entire Agreement | A-73 | |||||||
9.6 | Third Party Beneficiaries | A-73 | |||||||
9.7 | Severability | A-73 | |||||||
9.8 | Remedies | A-73 | |||||||
9.9 | Governing Law | A-75 | |||||||
9.10 | Consent to Jurisdiction | A-75 | |||||||
9.11 | WAIVER OF JURY TRIAL | A-75 | |||||||
9.12 | No Recourse | A-76 | |||||||
9.13 | Company Disclosure Letter References | A-76 | |||||||
9.14 | Counterparts | A-76 | |||||||
EXHIBITS | |||
Exhibit A | Certificate of Incorporation of the Surviving Corporation | ||
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
Term | Section Reference | ||
Agreement | Preamble | ||
Acquisition Proposal Notice Period | 5.3(c)(ii)(1) | ||
Alternative Acquisition Agreement | 5.3(a) | ||
Alternative Financing | 6.5(d) | ||
Capex Budget | 5.2(k) | ||
Capitalization Date | 3.7(a) | ||
Certificate of Merger | 2.2 | ||
Certificates | 2.10(c) | ||
Chosen Courts | 9.10(a) | ||
Closing | 2.3 | ||
Closing Date | 2.3 | ||
Closing Equity Award Consideration | 2.8(f) | ||
Closing Option Consideration | 2.8(a) | ||
Closing PSU Consideration | 2.8(f) | ||
Closing RSA Consideration | 2.8(d) | ||
Closing RSU Consideration | 2.8(f) | ||
Company | Preamble | ||
Company Board Recommendation | 3.3(a) | ||
Company Board Recommendation Change | 5.3(d)(i) | ||
Company Disclosure Letter | Article III | ||
Company PSU Restricted Cash Award | 2.8(h) | ||
Company IT Assets | 3.21 | ||
Company Related Parties | 8.3(e)(i) | ||
Company RSA Restricted Cash Award | 2.8(c) | ||
Company RSU Restricted Cash Award | 2.8(e) | ||
Company SEC Documents | Article III | ||
Company Securities | 3.7(c) | ||
Company Stockholder Meeting | 6.4(a) | ||
Company Subsidiary Securities | 3.8(c) | ||
Continuation Period | 6.11(a) | ||
Copyrights | 1.1(bbb) | ||
D&O Insurance | 6.10(c) | ||
Debt Commitment Letters | 6.6(a) | ||
Debt Financing | 6.6(a) | ||
DGCL | Recitals | ||
Dissenting Company Shares | 2.7(c) | ||
DTC | 2.10(d) | ||
DTC Payment | 2.10(d) | ||
Effective Time | 2.2 | ||
Electronic Delivery | 9.14 | ||
Enforceability Exceptions | 3.2 | ||
Equity Award Holders | 2.8(i) | ||
Equity Commitment Letters | 4.12(a) | ||
Equity Financing | 4.12(a) | ||
Equity Providers | 6.6(e) | ||
ESPP Offering Period | 2.8(d) | ||
Fee Letter | 4.12(a) | ||
Financing | 4.12(a) | ||
TABLE OF CONTENTS
Term | Section Reference | ||
Financing Letters | 4.12(a) | ||
Guarantee | Recitals | ||
Guarantor | Recitals | ||
Indemnified Persons | 6.10(a) | ||
Intervening Event Notice Period | 5.3(c)(i)(1) | ||
Lease | 3.14 | ||
Leased Real Property | 3.14 | ||
Legal Restraint | 8.1(b) | ||
Marks | 1.1(bbb) | ||
Material Customer | 1.1(jjj)(iii) | ||
Master Supplier | 1.1(jjj)(iv) | ||
Maximum Annual Premium | 6.10(c) | ||
Merger | Recitals | ||
Merger Sub | Preamble | ||
Multiemployer Plan | 3.18(c) | ||
New Commitment Letters | 6.5(d) | ||
New Plan | 6.11(b) | ||
Old Plans | 6.11(b) | ||
Other Indemnified Persons | 6.10(e) | ||
Other Required Company Filing | 6.3(b) | ||
Owned Company Shares | 2.7(a)(iii) | ||
Owned Real Property | 3.14 | ||
Parent | Preamble | ||
Parent Disclosure Letter | 4.13 | ||
Parent Material Adverse Effect | 7.3(a) | ||
Parent Related Parties | 8.3(e)(i) | ||
Parent Termination Fee | 8.3(c) | ||
Party | Preamble | ||
Patents | 1.1(bbb) | ||
Payment Agent | 2.10(a) | ||
Payment Fund | 2.10(b) | ||
Per Share Price | 2.7(a)(ii) | ||
Preferred Equity Financing Letters | 4.12(a) | ||
Proxy Statement | 6.3(a) | ||
Real Property | 3.14 | ||
Regulatory Concession | 6.2(b) | ||
Representative | 5.3(a) | ||
Requisite Stockholder Approval | 3.4 | ||
Restricted Cash Awards | 2.8(h) | ||
Restricted Cash Award Holders | 2.8(j) | ||
Surviving Corporation | 2.1 | ||
Termination Date | 8.1(c) | ||
Uncertificated Shares | 2.10(c) | ||
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
(a) if to Parent or Merger Sub to: | |||||||||
Mozart Parent, LLC c/o GTCR LLC | |||||||||
300 N. LaSalle Street, Suite 5600 | |||||||||
Chicago, IL 60654 | |||||||||
Attn: | Mark M. Anderson Nelson Iginla Jeffrey S. Wright | ||||||||
Email: | [***] [***] [***] | ||||||||
TABLE OF CONTENTS
with a copy (which will not constitute notice) to: | |||||||||
Simpson Thacher & Bartlett LLP | |||||||||
425 Lexington Avenue | |||||||||
New York, NY 10017 | |||||||||
Attn: | Elizabeth A. Cooper Katherine M. Krause | ||||||||
Email: | ecooper@stblaw.com katherine.krause@stblaw.com | ||||||||
(b) if to the Company (prior to the Effective Time) to: | |||||||||
CCC Intelligent Solutions Holdings Inc. | |||||||||
167 N. Green Street, 9th Floor | |||||||||
Chicago, IL 60607 | |||||||||
Attn: | Githesh Ramamurthy, Chief Executive Officer | ||||||||
Email: | [***] | ||||||||
with a copy (which will not constitute notice) to: | |||||||||
c/o CCC Intelligent Solutions Holdings Inc. | |||||||||
167 N. Green Street, 9th Floor | |||||||||
Chicago, IL 60607 | |||||||||
Attn: | Chief Legal Officer | ||||||||
Email: | [***] | ||||||||
with a copy (which will not constitute notice) to: | |||||||||
Kirkland & Ellis LLP | |||||||||
601 Lexington Avenue | |||||||||
New York, NY 10022 | |||||||||
Attn: | Sarkis Jebejian, P.C. Willard S. Boothby, P.C. William A. Stanton | ||||||||
Email: | sarkis.jebejian@kirkland.com willard.boothby@kirkland.com william.stanton@kirkland.com | ||||||||
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
MOZART PARENT, LLC | ||||||
By: | /s/ Mark M. Anderson | |||||
Name: | Mark M. Anderson | |||||
Title: | President | |||||
MOZART MERGER SUB (DE), INC. | ||||||
By: | /s/ Mark M. Anderson | |||||
Name: | Mark M. Anderson | |||||
Title: | President | |||||
TABLE OF CONTENTS
CCC INTELLIGENT SOLUTIONS HOLDINGS INC. | ||||||
By: | /s/ Githesh Ramamurthy | |||||
Name: | Githesh Ramamurthy | |||||
Title: | Chairman and Chief Executive Officer | |||||
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
MOZART PARENT, LLC | ||||||
By: | /s/ Mark M. Anderson | |||||
Name: | Mark M. Anderson | |||||
Title: | President | |||||
MOZART MERGER SUB (DE), INC. | ||||||
By: | /s/ Mark M. Anderson | |||||
Name: | Mark M. Anderson | |||||
Title: | President | |||||
CCC INTELLIGENT SOLUTIONS HOLDINGS INC. | ||||||
By: | /s/ Githesh Ramamurthy | |||||
Name: | Githesh Ramamurthy | |||||
Title: | Chairman and Chief Executive Officer | |||||
TABLE OF CONTENTS
1) | Reviewed certain publicly available financial statements and other business and financial information of the Company; |
2) | Reviewed certain internal financial statements and other financial and operating data concerning the Company; |
3) | Reviewed certain financial projections prepared by the management of the Company; |
4) | Discussed the past and current operations and financial condition and the prospects of the Company with senior executives of the Company; |
5) | Reviewed the reported prices and trading activity for the Company Common Stock; |
6) | Compared the financial performance of the Company and the prices and trading activity of the Company Common Stock with that of certain other publicly-traded companies comparable with the Company and their securities; |
7) | Reviewed the financial terms, to the extent publicly available, of certain comparable acquisition transactions; |
8) | Participated in certain discussions and negotiations among representatives of the Company and Parent and their financial and legal advisors; |
9) | Reviewed (a) the Merger Agreement, (b) the draft equity commitment letters and preferred equity commitment letter from certain investors substantially in the forms of the drafts dated October 14, 2026 and October 12, 2026, respectively, the executed Debt Commitment Letter from certain debt financing sources dated October 12, 2026 (collectively, the documents in this clause (b), the “Commitment Letters”), and (c) the draft limited guarantees substantially in the form of the drafts dated October 14, 2026 (the “Limited Guarantees”), and certain related documents; and |
10) | Performed such other analyses and considered such other factors as we have deemed appropriate. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
Very truly yours, | ||||||
MORGAN STANLEY & CO. LLC | ||||||
By: | /s/ Kris Caldwell | |||||
Kris Caldwell | ||||||
Managing Director | ||||||
TABLE OF CONTENTS

TABLE OF CONTENTS
